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Friedreich’s ataxia is the most common recessive ataxia in the Caucasian population. It is 
caused by a defect in the expression of the mitochondrial protein frataxin and leads to 
neurodegeneration. The main role of frataxin lies in iron-sulphur cluster biosynthesis and loss 
of the protein results in mitochondrial iron accumulation and diminished energy production 
within the cell. Although mitochondrial function is severely affected, little is known about the 
influence of frataxin deficiency on mitochondrial dynamics and homeostasis. 
In this work, I utilized previously established Drosophila melanogaster RNAi models of 
Friedreich’s ataxia. To unravel the effects of frataxin depletion on the mitochondrial network, 
I focused on glia and muscle tissue, since these RNAi lines are not very efficient in neurons. I 
could show that mitochondrial morphology is disturbed, in agreement with the compromised 
membrane potential and energy production. Through the use of autophagy markers like p62, 
GFP-Atg8a and the newly established mtRosella, I performed a detailed analysis of 
mitochondrial degradation in frataxin deficient flies. I could demonstrate that damaged 
mitochondria are successfully targeted for degradation via mitophagy and promoting autophagy 
slightly improves Friedreich’s ataxia phenotypes. 
To analyse potential genetic interactions between frataxin and genes involved in 
mitochondrial homeostasis, I carried out a forward genetic screen. This screen identified 
knockdown of Marf, the Drosophila homologue of Mitofusin, as a suppressor of Friedreich’s 
ataxia phenotypes in glia. Since Marf has been described to play a pivotal role in mitochondrial 
fusion, mitophagy and the interface between mitochondria and the ER, I examined how Marf 
silencing affects all three pathways in a frataxin deficient background. Interestingly, I could 
show that loss of frataxin triggers the ER stress response and identified ER stress as a key factor 
in the disease. Whereas mitochondrial morphology and degradation were unaffected by Marf 
silencing, it suppressed ER stress in frataxin-deficient cells and this was sufficient to improve 
locomotion, brain degeneration and lipid dyshomeostasis. Furthermore, application of the 
chemical TUDCA, a known attenuator of ER stress, was also able to partially rescue 
Friedreich’s ataxia phenotypes. 
These results suggest that the protection mediated by Marf knockdown is linked to its role 
in mitochondrial-ER contacts instead of mitochondrial fusion or degradation. Furthermore, ER 






1.1. Friedreich’s ataxia 
Friedreich’s ataxia (FRDA) is a recessive neurodegenerative disorder that was first 
described by Nikolaus Friedreich in the 19th century (Friedreich, 1863) and is the most common 
hereditary ataxia in the Caucasian population (Cossee et al, 1997). 
The disease commonly manifests at adolescence and progresses with age (Harding, 1981). 
Based on available data from studies in several European countries, prevalence in Europe 
occurs in a gradient from southwest (Spain) to northeast (Scandinavia), ranging from 1:20.000 
to 1:250.000 (Vankan, 2013). 
FRDA patients show several typical symptoms that can be categorized into neurological 
and non-neurological. Neurological symptoms include: gait ataxia; severe proprioceptive and 
superficial sensory loss; weakness and atrophy of the extremities; loss of muscle tone or 
spasticity; depressed reflexes; visual loss and hearing deficit. All patients require wheelchairs 
eventually. The following hallmarks comprise the neuropathology: degeneration of large 
sensory neurons in dorsal root ganglia; progressive degeneration of pyramidal tracts; major 
lesions in the dentate nucleus and demyelination of nerve fibers (Koeppen & Mazurkiewicz, 
2013). 
The most important non-neurological symptom is hypertrophic cardiomyopathy. Indeed, 
heart failure is the main cause of death among patients (Dürr et al, 1996). In addition, about 
25% of patients also suffer from diabetes mellitus (Filla et al, 1996). 
 
Figure 1: GAA triplet repeat in the FXN gene reduces frataxin levels 
GAA triplet repeat expansion in the first intron of frataxin results in decreased levels of frataxin. Most patients 
have expansions in both alleles (adapted from Gatchel & Zoghbi, 2005). 
The disease is caused by mutations in the frataxin (FXN) gene, most commonly an 
expansion of a GAA triplet repeat in the first intron (Campuzano et al, 1997). The number of 
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triplets in heathy people ranges from 10-40, while FRDA patients usually have over 500 repeats 
(Figure 1). Age of onset normally correlates inversely with triplet repeat length and patients 
with more repeats often suffer from faster progression (Montermini et al, 1997; Patel et al, 
2016). How the GAA triplet repeat facilitates loss of protein is still a matter of debate. One 
proposed mechanism is the formation of an intramolecular triple DNA helix called ‘sticky 
DNA’ in the repeat region, inhibiting transcription elongation (Potaman et al, 2004). 
Alternatively, inhibition of transcription initiation via epigenetic modifications at the FXN 
locus has been suggested (Greene et al, 2007; Sandi et al, 2013). Recent advancements imply 
that both factors may play a role in transcription inhibition (Li et al, 2015). Other mutations 
such as deletions or point mutations have been reported but are rare and always associated with 
a triplet repeat expansion in the other allele. These compound heterozygotes account for about 
2 - 4% of all cases (Cossee et al, 1999). 
All FRDA patients show a basal level of the frataxin protein and patients with a complete 
loss of frataxin have not been documented. In this sense, complete knockout of frataxin results 
in embryonic lethality in mouse and Drosophila (Cossee et al, 2000; Anderson et al, 2005). At 
present, no effective therapy for FRDA has been developed so far. 
1.2. The frataxin protein 
1.2.1. Frataxin structure 
The primary product of the FXN gene is a precursor protein of 210 amino acid length and 
23 kilodalton (kDa) size. It is then processed in a two-step maturation process into mature 
frataxin, constituting a 14.2 kDa mitochondrial protein composed of 130 amino acids 
(Schmucker et al, 2008). 
Crystal structure analysis revealed that frataxin forms an α-β sandwich and consists of two 
nearly parallel α helices and seven β strands (Dhe-Paganon et al, 2000). 
Frataxins are highly conserved among species, with homologues not only in animals, but 
also in plants, fungi and bacteria (Gibson et al, 1996; Campuzano et al, 1996; Koutnikova et al, 
1997). In agreement, their crystal structures are also nearly identical (Cho et al, 2000; He et al, 
2004). Eukaryotic frataxins share two highly conserved domains in their structure: An N-
terminal tail region containing a mitochondrial import signal (Gibson et al, 1996) and a C-
terminal region responsible for protein stability (Faraj et al, 2016). 
The high degree of homology among the molecular structure of different frataxins has 
allowed the establishment of many different models in order to elucidate the exact function of 
frataxin and its role in mediating FRDA. Such models include yeast (Foury & Cazzalini, 1997), 
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mouse (Puccio et al, 2001), C.elegans (Ventura et al, 2005; Vazquez-Manrique et al, 2006) and 
Drosophila melanogaster (Anderson et al, 2005; Llorens et al, 2007). 
1.2.2. Frataxin function 
Frataxin is present in all human cells, but expression levels differ depending on the tissue 
(Pandolfo, 2003). It is predominantly expressed in tissues with a high metabolic rate, including 
liver, kidney, neurons and heart. Not surprising, these are also the tissues where mitochondria 
are enriched (Koutnikova et al, 1997). 
 
Figure 2: Frataxin has a key role 
in ISC biogenesis 
The proposed main function of 
frataxin lies in ISC biogenesis, 
which involves the cysteine 
desulphurase NFS1-ISD11 and the 
scaffold protein ISCU. Frataxin can 
bind to this complex and increases 
the cysteine desulphurase activity, 
functioning as an allosteric 
activator (red arrow). In addition, 
frataxin has been proposed to 
supply iron to various 
mitochondrial proteins including 
succinate dehydrogenase (SDH), 
mitochondrial aconitase (mACO) 
and ferrochelatase (FCH). In vitro, 
frataxin also forms oligomeric 
structures that can store iron (from 
Martelli et al, 2012b). 
The precise biological role of frataxin as a key regulator of iron-sulphur cluster (ISC) 
biogenesis has been well established (Tsai & Barondeau, 2010; Schmucker et al, 2011; Pandey 
et al, 2013). ISCs are small inorganic cofactors that are involved in many essential cellular 
pathways including energy metabolism and various enzymatic reactions (Lill, 2009). According 
to the current model, the following proteins are involved in the formation of ISCs: ISCU, which 
serves as the scaffold on which the cluster is assembled; NFS1-ISD11, a cysteine desulphurase 
that provides sulphur, and FXN, which increases the cysteine desulphurase activity, thus 
working as an allosteric activator (Figure 2). In bacteria, frataxin has instead been described as 
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a repressor of cluster formation (Adinolfi et al, 2009; Iannuzzi et al, 2011), but this anomaly 
seems to be restricted to bacteria, as no evidence of this in eukaryotes has been published. 
Originally, it was thought that frataxin might provide iron for ISC formation due to its iron 
binding capacity, since frataxin was able to transfer iron to ISCU both in vitro and in bacteria 
(Yoon & Cowan, 2003; Layer et al, 2006). This model has been challenged by the works of 
Tsai & Barondeau and Schmucker et al, who used mammalian recombinant proteins to show 
that interaction of frataxin and the scaffold machinery is independent of iron, but increases the 
cysteine desulphurase activity of NFS1-ISD11. The physiological source of iron is still a 
disputed topic, as no conclusive evidence has been found for a particular donor. Therefore, it 
has been suggested there might me multiple sources of iron (Barupala et al, 2016). 
Apart from this main function, frataxin has been proposed to be involved in other pathways, 
such as providing iron directly to succinate dehydrogenase, mitochondrial aconitase and 
ferrochelatase (Gonzalez-Cabo et al, 2005; Bulteau et al, 2004; Yoon & Cowan, 2004). 
However, different approaches failed to reproduce some of these interactions (Schmucker et al, 
2011). Therefore, the relevance of these functions is still a matter of debate. 
Additionally, frataxin in yeast is capable of forming oligomers when exposed to excess 
iron, which suggests an excess sequestration function (Adamec et al, 2000). However, this task 
seems to be restricted to yeast, likely because yeast lacks the common mitochondrial iron 
storage protein mitoferritin (Chiang et al, 2016). 
1.2.3. Metabolic and cellular consequences of frataxin depletion 
Even though it is still disputed which roles frataxin does ultimately perform in vivo, a 
common thread of all proposed functions is iron metabolism. Thus, it comes as no surprise that 
iron accumulation in the form of intracellular iron deposits was one of the first cellular 
symptoms of FRDA to be described (Lamarche et al, 1980). 
Over the years, the following alterations have been established as the main consequences 
of frataxin deficiency: Impairment of ISC biogenesis, altered cellular iron metabolism, 
mitochondrial dysfunction resulting from iron overload, and increased oxidative stress 
(Pandolfo, 2012). 
The scaffold machinery for ISC biogenesis is essentially in an off state when frataxin is 
absent and cannot synthesize new clusters (Tsai & Barondeau, 2010). This results in reduced 
activities of multiple proteins dependent on ISC clusters: Aconitase and complexes I, II, and III 
of the respiratory chain are among the prime enzymes affected (Rötig et al, 1997). In turn, this 
impacts the pathways these proteins are involved in, most importantly the citric acid cycle and 
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the electron transport chain in mitochondria, leading to loss of mitochondrial membrane 
potential and reduced ATP production (Shidara & Hollenbeck, 2010; Bolinches-Amoros et al, 
2014). 
A consequence of dysfunctional ISC biogenesis is enhanced activity of the cytosolic iron 
regulatory protein 2 (IRP2). It is involved in the control of iron metabolism by binding mRNA 
to repress translation or degradation (Eisenstein, 2000). IRP2 activation results in altered levels 
of proteins implicated in iron flux and distribution, altogether leading to a continuous iron 
transport into the mitochondria and accompanying cytosolic iron depletion. (Whitnall et al, 
2008; Huang et al, 2009). If not used in a biosynthetic process, excess iron in mitochondria then 
can become oxidized and form insoluble precipitates (Koeppen, 2011). In particular, surplus 
iron in conjunction with reactive oxygen species (ROS), primarily hydrogen peroxide (H2O2), 
produces highly toxic free radicals in the so-called Fenton reaction (Fe2+ + H2O2 → Fe3+ + OH- 
+ OH∙). The hydroxyl radical OH
∙ produced by this reaction then damages many intracellular 
components such as proteins, DNA and membrane lipids (Delatycki et al, 2000). Heightened 
levels of oxidative stress markers have been found in patient samples (Emond et al, 2000; 
Schulz et al, 2000). Increased oxidative stress is also a hallmark of several FRDA models such 
as cell culture , C.elegans and Drosophila (Wong et al, 1999; Vazquez-Manrique et al, 2006; 
Llorens et al, 2007). Consequently, it has been shown that H2O2 detoxification protects frataxin 
deficient cells from oxidant damage (Pastore et al, 2003; Anderson et al, 2008). Likewise, 
sequestration of Fe2+ ions by overexpression of mitochondrial ferritin was able to reduce 
oxidative damage in FRDA fibroblasts (Campanella et al, 2009). 
Unfortunately, clinical studies with the antioxidant idebenone revealed no significant effect 
on patients (Lagedrost et al, 2011; Meier et al, 2012). In similar fashion, the iron chelator 
deferiprone has been evaluated, but results remain inconclusive, even though some parameters 
showed encouraging trends (Pandolfo & Hausmann, 2013). 
Another pathway affected in FRDA patients is lipid metabolism. In Drosophila, frataxin 
knockdown results in an increase in fatty acids metabolism and enhanced lipid peroxidation 
levels (Navarro et al, 2010). Similarly, lipid accumulation was observed in mouse models of 
frataxin deficient cardiomyocites and liver (Puccio et al, 2001; Martelli et al, 2012a; Obis et al, 
2014). Signs of altered lipid metabolism have also been found in patients (Swarup et al, 2013). 
A possible mechanism is the differential regulation of PPARγ and its co-activator PGC1α found 
in a mouse model of FRDA. PPARs are nuclear receptors that serve as transcriptional sensors 
of fatty acids and play key roles in lipid regulation by repressing genes involved in lipogenesis. 
Interestingly, the exact response differed from tissue to tissue, likely because PGC1α is able to 
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activate tissue-specific transcription factors, triggering diverse metabolic programs in different 
tissues (Coppola et al, 2009). 
Furthermore, it has been proposed that the prevalence of diabetes in FRDA patients might 
be connected to lipid metabolism dysfunctions. A clinical trial testing the drug pioglitazone, 
used for treating diabetes, has been completed but study results remain unpublished so far 
(Tamarit et al, 2016). 
1.3. Glia and skeletal muscles in FRDA 
1.3.1. The role of glial cells 
Apart from neurons and the heart muscle, the primarily affected tissues, other cell types 
with an abundant expression of frataxin also display pathological manifestations. A premier 
example are glial cells. Glia are a class of non-neuronal cells that provide support and protection 
for neurons in the central and peripheral nervous systems. The main tasks of glia are to hold 
neurons in place and to supply nutrients and oxygen to neurons. It has recently been established 
that glia also play a crucial role in synapse formation and directly communicate with neurons 
(Stogsdill & Eroglu, 2017). 
In FRDA, demyelination of the large axons has been reported in patients, along with 
abnormal Schwann cell morphology (Morral et al, 2010). In agreement, cultured Schwann cells 
were severely affected by lack of frataxin, leading to inflammation and ultimately cell death 
(Lu et al, 2009). Demyelination of large axons was also detected within the lumbar roots of a 
mouse model (Al-Mahdawi et al, 2006). Furthermore, targeted loss of frataxin in Drosophila 
glia caused defects in lipid metabolism, increased sensitivity to oxidative insult and impairment 
of locomotor activity (Navarro et al, 2010). More recently, a study of frataxin silencing in 
human astrocytes revealed detrimental effects not only cell-autonomously, but also for neuron-
glia interactions (Loria & Diaz-Nido, 2015). In fact, lipid droplet accumulation in glia following 
mitochondrial dysfunction seems to be a key consequence of ROS in several neurodegenerative 
diseases (Liu et al, 2015). 
1.3.2. The glial network of Drosophila 
Unlike mammals, in which glia comprise almost 90% of brain cells, insect nervous systems 
have far fewer glial cells. Only 10% of the 90,000 cells estimated to occur in the adult central 
nervous system (CNS) of Drosophila can be identified as glial cells (Edwards & 
Meinertzhagen, 2010). Furthermore, even though Schwann cells and myelin sheaths cannot be 
found in insects, fly glia also generate multi-layered membrane protections around neurons and 
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axons. Not surprisingly, glia in the fruit fly are equally important as the ones found in mammals 
and share the same characteristics and are able to perform the same tasks as their mammalian 
counterparts (Stork et al, 2012). 
In Drosophila, glia of the CNS can be divided into three major groups based on their 
location: Surface, cortex and neuropil glia (Figure 3). 
Surface glia comprise the outermost glia of the brain and can further be subdivided into 
two categories, an outer layer (perineurial) and an inner layer (subperineurial). While the exact 
role of perineurial glia remains unclear, subperineurial glia form an effective blood-brain barrier 
which excludes molecules over a certain size over from entering the CNS (Stork et al, 2008). 
Cortex or cell body glia envelop the somata of neurons in the outer layer of the brain 
(cortex). Cortex glia of the optic lobe are called satellite glia. They serve an important function 
in the maintenance of neurons, as well as in proper layering of neuronal cell bodies in the 
developing brain. 
 
Figure 3: Classification of glia in the Drosophila 
brain 
Schematic cross section of a fly brain showing the 
exterior cortex (neuronal and glial cell bodies), 
central neuropil (neuronal and glial processes), and 
glial cells. The three major classes of glial cells are 
represented in different colors (adapted from 
Hartenstein, 2011). 
 
Neuropil glia surround the axons of neurons by extending sheath-like membranes around 
fibre bundles to form an isolation similar to myelin sheaths. They are the most diverse type of 
glia and can be broadly subdivided into two structurally distinct types: Ensheathing glia are 
lamellar and surround axons along the outer surface of the neuropil area. Reticular or astrocyte-
like glia are widely branched, forming a network with terminal axons and synaptic regions 
(Awasaki et al, 2008). Neuropil glia fulfil several important tasks within the insect brain: They 
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serve as a guidance mechanism for axons, are involved in neuronal apoptosis and participate in 
synaptic transmission by taking up transmitters from the synaptic cleft (Hartenstein, 2011). 
1.3.3. Involvement of skeletal muscle in FRDA 
Although mitochondria are highly abundant in skeletal muscles because of their ample 
energy demands, muscle symptoms are overall less prominent than neurological ones. 
Nonetheless, FRDA patients display general muscle weakness, most prominent in the hip, and 
progressive loss of muscle strength in the distal limbs (Beauchamp et al, 1995; Dürr et al, 1996). 
Because the symptoms are milder, the effect of frataxin depletion on skeletal muscles has 
been incompletely characterized. Magnetic resonance spectroscopy of calf muscles in FRDA 
patients revealed impaired mitochondrial respiration and ATP synthesis in addition to delayed 
recovery of tissue oxygenation after exercise (Lodi et al, 1999; Lynch et al, 2002; Nachbauer 
et al, 2012). However, a recent study that used the forearm instead of calf failed to reproduce 
these findings, though the authors could detect a correlation between reduced mitochondrial 
capacity and the severity of the disease (Bossie et al, 2016). Overall, involvement of skeletal 
muscle tissue in FRDA remains poorly understood. 
1.4. Mitochondrial dynamics 
1.4.1. FRDA is a mitochondriopathy 
Frataxin is a mitochondrial protein and therefore FRDA at its core should be considered a 
mitochondrial disease. Indeed, due to its similarities to other mitochondrial diseases, it is 
classified as a member of the family of neurodegenerative mitochondriopathies (Swerdlow, 
2009). 
Mitochondria are self-dividing organelles responsible for generating cellular energy via 
ATP synthesis, regulating intracellular calcium levels, altering the redox potential of cells and 
regulating apoptosis. Increasing evidence suggests that alterations in these tasks play a central 
role in the development and progression of neurodegenerative diseases. Correspondingly, a 
common thread of mitochondriopathies are increased generation of free radicals, low 
production of cellular ATP, mitochondrial DNA damage and ultimately cell death. (Reddy, 
2008). 
1.4.2. The role of fusion and fission 
Electron micrographs showing solitary, bean-shaped organelles have largely inspired the 
textbook appearance of mitochondria as singular structures within the cell. In the 1980s, live-
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cell studies finally showed that mitochondria are actually highly dynamic organelles that are 
organized in large, intracellular networks (Bereiter-Hahn, 1990). 
 
Figure 4: Biological functions of mitochondrial dynamics 
(A) During their life cycle, mitochondria undergo many fission and fusion events, forming either interconnected 
mitochondrial networks or numerous heterogeneous mitochondria, depending on the physiological conditions. (B) 
Both interconnected networks and solitary mitochondria fulfil distinct and important roles in the cell (adapted from 
Westermann, 2010b). 
Mitochondria frequently fuse and divide within the cell, depending on the physiological 
conditions. Fusion generates large networks of interconnected mitochondria, whereas fission 
results in multiple mitochondrial fragments (Figure 4A). Mitochondria themselves cannot be 
generated de novo. Instead, new mitochondria are formed by the growth and division of pre-
existing organelles. This process involves the import of mitochondrial proteins encoded by the 
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nucleus, amplification of the mitochondrial DNA (mtDNA) and translation of proteins encoded 
by said DNA (Westermann, 2010b). During their life cycle, active mitochondria are transported 
through the cell via the actin cytoskeleton by myosin motor proteins (Altmann et al, 2008). 
Finally, surplus or damaged organelles are degraded through macroautophagy, in a process 
called mitophagy (Kim et al, 2007). 
The structure of the mitochondrion is the key factor in determining the function it performs 
within the cell (Figure 4B). Mitochondrial networks can be found in metabolically active cells 
under conditions of high energy demand, such as neurons and muscles (Westermann, 2012). 
Large, interconnected networks show increased levels of mitochondrial respiration. In addition, 
they are responsible for the transmission of membrane potential along the cell, enabling the 
production of ATP in remote parts. Furthermore, mitochondrial fusion is required for the repair 
of mutations in the mtDNA via complementation, serving as defence mechanism against 
ageing. If two mitochondria, which carry mutations in different genes, fuse, the resulting 
organelle will feature an intact allele of both genes and therefore be able to bypass the defect 
(Ono et al, 2001). 
Correspondingly, inhibition of mitochondrial fusion resulted in mitochondrial dysfunction, 
compensatory mitochondrial proliferation, accumulation of point mutations in the 
mitochondrial genome and depletion of mtDNA in mouse (Chen et al, 2010). 
Mitochondrial fission also serves a variety of purposes. It is required for production of 
additional mitochondria and proper distribution of mitochondria to daughter cells. Moreover, 
fission is required for the generation of transportable mitochondria for movement along the 
cytoskeleton. Early during apoptosis, mitochondrial fragmentation triggers the release of pro-
apoptotic factors such as cytochrome c into the cell (Martinou & Youle, 2011). Lastly, fission 
serves to eliminate damaged organelles by mitophagy, contributing to the maintenance of a 
healthy mitochondrial population (Kim et al, 2007). 
Considering the huge variety of functions mediated by mitochondria, it is obvious that 
disturbances in mitochondrial homeostasis have severe consequences at the cellular level. As 
neurons generally have the highest energy consumption rate of all cells, defects in the intricate 
system of fusion and fission particularly affect neuronal function. Thus, dysfunctions in 
mitochondrial dynamics are predominantly associated with neurodegenerative diseases such as 
Parkinson’s disease, Alzheimer’s disease and Huntington’s disease (Itoh et al, 2013). 
In FRDA, several mitochondrial pathways have been studied in detail so far, including 
bioenergetics, redox status and iron homeostasis. However, information about mitochondrial 
dynamics and quality control is scarce (Gonzalez-Cabo & Palau, 2013). Increased 
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mitochondrial fragmentation has been observed in yeast and C.elegans (Lefevre et al, 2012; 
Schiavi et al, 2015). In contrast, frataxin knockdown triggered the formation of enlarged 
mitochondria in mammals (Puccio et al, 2001; Bolinches-Amoros et al, 2014; Obis et al, 2014). 
Furthermore, accumulation of normal mitochondria and the occurrence of mitochondria with 
disorganized cristae have been reported in cultured human cells (Hick et al, 2013). This suggests 
that the mitochondrial response might depend on the physiology and the adaptation capacity of 
the cell type. 
1.4.3. Regulators of mitochondrial dynamics 
1.4.3.1. The master regulators of fusion and fission 
Extensive research over the years has led to a profound knowledge about the regulators of 
mitochondrial dynamics. The core mediators of fusion and fission are three membrane-
remodelling enzymes, which belong to the dynamin family of large GTPases: Mfn (mitofusin; 
named Marf in Drosophila) and Opa1 (optic atrophy 1) are responsible for fusion, while Drp1 
(dynamin-related protein 1) regulates fission (Figure 5). 
 
Figure 5: The key regulators of mitochondrial fusion and fission 
(A) Mfn1/2 and Opa1 mediate fusion of outer and inner mitochondrial membrane, respectively. (B) For fission, 
cytosolic Drp1 is recruited to the outer mitochondrial membrane via molecular adaptor proteins (adapted from 
Mishra & Chan, 2014). 
Mfn is required for fusion of the outer mitochondrial membrane (OM) and consists of two 
transmembrane domains, a short loop in the intermembrane space and the major part extending 
into the cytosol. In mammals, two functionally interchangeable isoforms of Mfn exist (Koshiba 
et al, 2004). In the first step, Mfn proteins of opposing mitochondria come in contact with each 
other and form a tether between them. Then, fusion of the OM occurs in a GTP hydrolysis-
dependent manner. After the completion of OM fusion, Opa1 is required for inner 
mitochondrial membrane (IM) fusion and operates in a similar way: tethering with subsequent 
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fusion through GTP hydrolysis (Lee & Yoon, 2016). Opa1 itself is anchored within the IM, 
with the major part expanding into the intermembrane space (Meeusen et al, 2006). 
Drp1 is the master regulator of mitochondrial fission. Drp1 is primarily found in the cytosol 
and is only recruited onto the OM during the fission process (Legesse-Miller et al, 2003). 
Assembly requires interaction with partner proteins located in the OM and causes the 
constriction of mitochondria and eventual division into two separate organelles. Multiple 
receptors are able to recruit Drp1 to the site of mitochondrial fission. Four of these interaction 
partners have been characterized so far in mammals: Fis1, Mff, MiD49 and MiD51 (Mishra & 
Chan, 2014). 
1.4.3.2. Drosophila as a model organism for mitochondrial dynamics 
The three core proteins of mitochondrial fusion/fission are well conserved among different 
species and the fruit fly has been a valuable asset in identifying the proteins involved. The first 
known mediator of mitochondrial fusion, Fzo (fuzzy onions), was discovered in Drosophila 
and established the field of mitochondrial dynamics (Hales & Fuller, 1997). It is only expressed 
in testis of male flies, reflecting a highly specialized function. The protein Marf (Mitochondrial 
assembly regulatory factor) fulfils a more general role as the homologue of the mammalian 
fusion protein Mfn. In contrast to mammals, there is only one variant of Marf present in the fly 
(Deng et al, 2008). Opa1 and Drp1 have orthologues in Drosophila that perform the same roles 
as their mammalian counterparts. 
Compared to the three main regulators, the Drp1 receptors on the OM membrane seem less 
conserved. While Fis1 is the only receptor in yeast, it is less important in both mammals and 
flies (Westermann, 2010a). In mammals, Mff (Mitochondrial fission factor) seems to be the 
primary receptor, as loss of Mff causes the greatest decrease in fission (Loson et al, 2013). Mff 
is also present in Drosophila and is able to mediate fission (Gandre-Babbe & van der Bliek, 
2008), but no further analysis has been done in the fly. 
Apart from these main players, two further proteins have been shown to influence 
mitochondrial dynamics in Drosophila: Pink1 and Parkin, key factors involved in the 
pathogenesis of Parkinson’s disease. While their main role lies in acting as checkpoints of 
mitochondrial integrity and in targeting mitochondria for degradation when necessary (see 
chapter 1.5.2), it has been suggested that they are also able to regulate mitochondrial 
morphology (Clark et al, 2006). Several reports have demonstrated that Pink1 and parkin 
interact genetically with the fusion/fission machinery to promote mitochondrial fission and/or 
inhibit fusion. Overexpression of Drp1 or knockdown of Marf is able to ameliorate the muscle 
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degeneration and mitochondrial abnormalities found by Pink1 and Parkin mutants (Deng et al, 
2008). In addition, Pink1 overexpression promotes mitochondrial fission, whereas inhibition 
leads to excessive fusion (Yang et al, 2008). Similarly, loss of Pink1 results in increased 
mitochondrial fusion in C.elegans (Luz et al, 2015). However, in human cell culture Pink1 and 
Parkin knockdown appeared to have the opposite effect, promoting fusion instead of fission 
(Lutz et al, 2009). 
Altogether, these results suggest that Pink1 and Parkin are likely involved, but not core 
components of the fusion/fission machinery. 
1.5. Autophagy in neurodegenerative diseases 
Autophagy in general refers to a group of intracellular degradation pathways that mediate 
the breakdown of intracellular material such as proteins, lipids and even whole organelles 
including mitochondria in the lysosome. Several subtypes of autophagy have been described so 
far, but most research has been dedicated to macroautophagy, as it is the most important 
pathway with the highest capacity for degradation. It is also the only pathway capable of 
organelle turnover (Mulakkal et al, 2014). 
Neurons are particularly vulnerable to defects in this system because of their size and lack 
of cell division. Without functional autophagy, neurons accumulate protein aggregates and 
ultimately degenerate, as toxic waste cannot be diluted through self-replication. Therefore, it is 
not surprising that mutations in autophagy-related genes are closely linked to neurodegenerative 
diseases (Nixon, 2013). 
1.5.1. The macroautophagy pathway 
Macroautophagy, hereafter simply referred to as autophagy, includes several steps (Figure 
6). The master regulator of autophagy is the serine/threonine kinase Tor (target of rapamycin) 
(Noda & Ohsumi, 1998). Tor activity is highly dependent on the presence of nutrients and 
stimulates protein synthesis. Under starvation conditions, Tor is inhibited, which in turns shuts 
down translation and induces autophagy (Scott et al, 2004; Figure 6A). 
After induction, Atg1 (autophagy related 1) is activated via phosphorylation, recruits the 
Atg1 protein kinase complex and initiates the formation of the isolation membrane or 
phagophore. In turn, this triggers the translocation of a multi-protein complex from the 
cytoskeleton to the phagophore assembly site and induces vesicle elongation, forming a closed 




Figure 6: Schematic overview over the main steps of autophagy 
(A) Under starvation conditions, the autophagy master regulator Tor is inhibited. In turn, this activates Atg1 and 
induces vesicle nucleation. (B) Cargo selected for degradation is polyubiquitinated and becomes linked to the 
phagophore via p62 and Atg8. (C) After autophagy induction, the isolation membrane or phagophore forms 
(vesicle nucleation). The phagophore is then expanded through the interaction of the autophagy core machinery 
proteins at the phagophore assembly site, forming the autophagosome (vesicle elongation). It can engulf targeted 
cargo, including proteins or even whole organelles, specifically. The autophagosome then fuses with a lysosome 
to form the so called autophagolysosome (docking & fusion). Finally, the contents of the autophagolysosome are 
degraded by the lysosomal hydrolases and can be recycled (vesicle breakdown & degradation). Adapted from 
Melendez & Levine, 2009. 
While autophagy originally emerged as a non-selective process, it can also target proteins 
or organelles specifically. Atg8 is a protein anchored to the inside of the phagophore during 
vesicle elongation and is able to bind selected cargo via distinct receptor proteins that serve as 
adapters between Atg8 and the substrate. One of these receptors is p62, which recognizes 
ubiquitinated proteins that have been targeted for degradation and links them to Atg8, thus 
connecting them to the phagophore (Johansen & Lamark, 2011; Figure 6B). 
After autophagosome formation is complete, it fuses with intracellular lysosomes to so-
called autolysosomes. Through Vacuolar-type H+-ATPase (vATPase) activity, a multimeric 
proton pump in the lysosomal membrane, the interior of the autolysosome becomes acidic, 
activating hydrolases. The contents of the autolysosome are then digested and released into the 




Autophagy is also responsible for selective degradation of defective mitochondria, a 
process dubbed mitophagy. While recent advancements have uncovered additional pathways 
for targeting mitochondria for degradation, the best understood pathway is the Pink1/Parkin-
mediated mitophagy, originally discovered in Drosophila (McWilliams & Muqit, 2017). A 
schematic overview can be seen in Figure 7. 
 
Figure 7: Mechanism of Pink1/Parkin induced mitophagy 
(A) In healthy mitochondria, Pink1 imported to the mitochondria is rapidly degraded, resulting in low levels of 
Pink1 on the outer mitochondrial membrane. (B) Following loss of membrane potential, Pink1 is stabilized on the 
outer membrane and recruits Parkin to ubiquitinate mitochondrial membrane proteins. Ubiquitinated proteins are 
recognized by the autophagy receptor protein p62 and guided towards the phagophore, resulting in engulfment of 
the mitochondrion. The phagophore then matures into an autophagosome and fuses with lysosomes to form the 
autolysosome (adapted from Exner et al, 2012). 
Under normal conditions, Pink1 is constantly imported onto the outer mitochondrial 
membrane and rapidly degraded (Jin et al, 2010). When import is disrupted because of 
mitochondrial depolarization, Pink1 is stabilized and accumulates on the outer membrane. 
Pink1 then recruits the E3 ubiquitin ligase Parkin and activates it through its kinase activity 
(Lazarou et al, 2012).  
In turn, Parkin ubiquitinates several target proteins located in the outer membrane, among 
them Marf (Ziviani et al, 2010). Ubiquitinated proteins are then recognized by autophagy 
receptors such as p62 to guide them towards the phagophore through binding to Atg8 (Pickrell 
& Youle, 2015). Subsequently, the phagophore closes around the organelle to form an 
autophagosome and the process continues as described in chapter 1.5.1. 
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More recently, Pink1 has emerged as the key regulator of mitophagy. According to the 
updated model, phosphorylation of ubiquitinated proteins on the outer mitochondrial membrane 
by Pink1 initiates mitophagy, while additional ubiquitination via Parkin amplifies the signal 
(Lazarou et al, 2015). 
1.5.3. Autophagy defects are closely tied to neurodegeneration 
Defects in autophagy have been recognized to be of major importance in the pathology of 
most neurodegenerative diseases. Disturbances in every step of the pathway have been 
associated with them, from autophagy induction over substrate recognition to lysosomal 
digestion (Kiriyama & Nochi, 2015). 
In Huntington’s disease, Tor is sequestered into huntingtin aggregates, reducing its activity 
(Ravikumar et al, 2004). Mutations in the autophagy receptor p62 have been implicated in 
amyotrophic lateral sclerosis (Fecto et al, 2011). Defects in vATPase targeting to lysosomes 
results in impaired acidification in a mouse model of Alzheimer’s disease (Lee et al, 2010). A 
hallmark of Parkinson’s disease is the accumulation of damaged mitochondria. In some forms, 
mutations in the mitochondrial quality control genes Pink1 and Parkin prevent damaged 
mitochondria from degradation, ultimately resulting in neuronal cell loss (Nguyen et al, 2016). 
As autophagy appears to be a central component of virtually every neurodegenerative 
disease, it is conceivable that autophagy, and particularly mitophagy, might be affected in 
FRDA as well. Information about mitophagy function in Friedreich’s ataxia, however, is 
limited. In a conditional mouse knockout model, Atg8 and p62 expression was increased and 
this correlated with increased expression of a mitophagy marker (Huang et al, 2013). Further 
studies could show that frataxin knockdown results in increased basal autophagy levels in 
C.elegans and human cell culture (Schiavi et al, 2013; Bolinches-Amoros et al, 2014). In case 
of the worm, this corresponded to enhanced mitophagy (Schiavi et al, 2015). 
Apart from that, no detailed analysis has been done in vivo to examine mitophagy in FRDA. 
1.6. Endoplasmic reticulum stress in the pathogenesis of neurodegenerative 
diseases 
1.6.1. The unfolded protein response 
The endoplasmic reticulum (ER) is an important organelle within the cell responsible for 
synthesis and export of proteins as well as Ca2+ homeostasis. Within the ER lumen, newly 
formed secretory and membrane proteins are correctly folded and transported from the rough 
ER to the Golgi apparatus. Disruptions in these processes lead to the accumulation of unfolded 
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proteins within the ER and trigger the unfolded protein response (UPR) (Wu & Kaufman, 
2006). An overview can be seen in Figure 8. 
 
Figure 8: Overview over the unfolded protein response 
The unfolded protein response (UPR) can be divided into three branches. All branches consist of a sensor (Ire1, 
PERK and ATF6) that recognizes unfolded proteins within the ER and triggers downstream pathways to 
reestablish correct protein folding within the ER. In the Ire1 branch, Xbp1 is spliced and translated. PERK 
phosphorylates eIF2α, who in turn activates ATF4. In the ATF6 branch, its cytosolic region is cleaved and liberated 
into the cytosol. Xbp1, ATF4 and ATF6 then function as transcription activators in the nucleus for target genes 
such as the ER chaperone BiP (adapted from Korennykh & Walter, 2012). 
The UPR can be divided into three branches which work in a similar fashion. They consist 
of two central components: A stress sensor located in the ER membrane and a downstream 
transcription factor that activates target genes responsible for restoring ER homeostasis such as 
the ER chaperone BiP. The most conserved of the three is the Ire1 branch. Upon ER stress, Ire1 
oligomerizes and is autophosphorylated. This triggers its RNAse activity and catalyses the 
unconventional splicing of Xbp1. Only spliced Xbp1 is translated into a functional protein, 
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transported into the nucleus and functions as a transcription activator. In the second branch, 
PERK dimerizes and phosphorylates eIF2α, ablating the translation initiation block for the 
transcription factor ATF4. In the last branch, the stress sensor ATF6 is cleaved and its cytosolic 
part can translocate into the nucleus to activate gene transcription (Xiang et al, 2017). 
Downstream effects of the UPR include upregulation of genes involved in the ER-
associated protein degradation, autophagy and quality control. Under conditions of irreversible 
or prolonged ER stress, the UPR is also able to mediate apoptosis (Hetz & Mollereau, 2014). 
1.6.2. ER stress in neurodegeneration 
Recently, ER stress and the unfolded protein response have come to the forefront as a 
common pathological symptom of neurodegenerative diseases, similar to autophagy. 
Accumulation of dysfunctional proteins are associated with Parkinson’s disease and 
Alzheimer’s disease, among others (Hetz & Mollereau, 2014).  
In Parkinson’s disease, Lewy bodies are formed within the brain consisting of mutant α-
synuclein. Elevated levels of PERK and phosphorylated eIF2α have been found in post-mortem 
brain tissue of patients (Hoozemans et al, 2007). In several models of Parkinson’s disease, 
ablation of Xbp1 resulted in loss of dopaminergic neurons, suggesting a neuroprotective effect 
of the Ire1 branch (Xiang et al, 2017). 
Accumulation of amyloid-β plaques and neurofibrillary tangles are a hallmark of 
Alzheimer’s disease. Similar to Parkinson’s disease, elevated levels of PERK and 
phosphorylated eIF2α are also present in this disorder and are thought to mediate neuronal cell 
loss by triggering apoptosis (Rozpedek et al, 2015). 
Originally, it was thought that UPR activation is a direct consequence of protein misfolding 
disorders and contributes to neuronal damage. However, this view has been challenged recently, 
as UPR signalling has been shown to both enhance and reduce neurodegeneration, depending 
on the branch that was activated (Hetz & Mollereau, 2014). Moreover, activation of the UPR 
has been implicated as a general, indirect response to external stressors, preceding the actual 
pathology. This is in agreement with the fact that most proteins related to neurodegeneration 
are located in the cytoplasm and are not connected to the ER in any stage of their life cycle. 
This suggests that ER stress might be part of the aetiology of most neurodegenerative diseases 
(Scheper & Hoozemans, 2015). 
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1.6.3. Mitochondria-ER contacts 
Interestingly, the ER and mitochondria form a dynamic interconnected network within the 
cell. In particular, it is estimated that about 5 – 20% of the mitochondrial surface is in close 
proximity to the ER, forming the so called mitochondria-associated ER membranes (MAMs). 
These contacts enable communication between mitochondria and the ER to regulate several 
essential cellular processes: Ca2+ and phospholipid exchange, intracellular trafficking, 
autophagy and mitochondrial biogenesis (Rowland & Voeltz, 2012). 
Naturally, MAMs are disrupted in multiple neurodegenerative diseases such as 
Alzheimer’s disease and Parkinson’s disease (Zampese et al, 2011; Cali et al, 2013). 
Despite their importance, the mechanism of tethering between mitochondria and the ER 
remains poorly understood. In yeast, the ER-mitochondria encounter structure has been 
described as the tether between ER and mitochondria (Kornmann et al, 2009), but this structure 
appears to be yeast specific. Several studies were able to identify proteins on the ER and the 
outer mitochondrial membrane that are able to interact with another, suggesting possible 
tethering complexes (Figure 9). 
 
Figure 9: Overview over proposed ER-mitochondria tethering complexes 
ER-located proteins are shown at the top, mitochondrial proteins shown at the bottom. The name of known 
Drosophila homologues is written in parentheses. PTPIP51 is vertebrate specific (adapted from Paillusson et al, 
2016). 
These four predicted tethering complexes are associated with a specific role they are 
proposed to mediate. IP3R and VDAC (Itpr and Porin in Drosophila) in conjunction with the 
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coupling protein Grp75 facilitate Ca2+ exchange. Interestingly, the fusion protein mitofusin has 
also been predicted to play a role in tethering mitochondria to the ER, possibly in Ca2+ transfer. 
The role of VAPB and PTPIP51 is to promote lipid transport, while Bap31 and Fis1 have been 
connected to apoptosis signaling (Phillips & Voeltz, 2016). No PTPIP51 homologues are 
present in Drosophila, C.elegans or yeast, thus the VAPB-PTPIP51 complex appears to be 
vertebrate specific. By contrast, orthologues of the other proteins exist in Drosophila as well 
(Paillusson et al, 2016). CG13887, the Drosophila orthologue of Bap31, will be called Bap31 
from now on. Additionally, Miro, a component of the mitochondrial transport machinery, 
interacts with both the Itpr-Porin and Marf complexes to facilitate Ca2+ transfer in the fruit fly 
(Lee et al, 2016). However, ER-mitochondrial contacts have not been studied in detail in 
Drosophila so far. 
Recently, MAM disruptions have been directly linked to the UPR. Loss of mitofusin 
promotes ER stress and modulates the UPR via inhibition of PERK. In turn, PERK might also 
be able to regulate mitochondrial morphology through its interaction with Mfn (Ngoh et al, 
2012; Munoz et al, 2013). Furthermore, several ER chaperones including BiP can be found 
within MAMs (Hayashi et al, 2009). 
Thus, it is possible that crosstalk between the ER and mitochondria facilitates not only ER 
stress and activates the UPR, but has a direct impact on mitochondrial homeostasis as well. 
1.7. The Drosophila model of Friedreich’s ataxia 
After the protein responsible for Friedreich’s ataxia was discovered in humans in 1997, the 
search for frataxin homologues (fh) in other species began quickly. Frataxin was found to exist 
in virtually every organism (see chapter 1.2.1) and the putative Drosophila homologue, located 
on the X chromosome, was first described shortly thereafter (Canizares et al, 2000). The protein 
shares the same secondary structural elements as its human counterpart and also exhibits strong 
iron binding capacity. Finally, it was shown to be capable of mediating the formation of ISCs 
in vitro (Kondapalli et al, 2008). Furthermore, overexpression of the human protein is able to 
rescue frataxin depletion in flies, suggesting a functional equivalence (Navarro et al, 2011; 
Tricoire et al, 2014; Chen et al, 2016). 
1.7.1. Two RNAi models for FRDA 
After its discovery, the first working model of FRDA in Drosophila was established in 
2005 by Anderson et al. Because, like in mammals, complete knockout of frataxin is embryonic 
lethal, this model mimics the pathology of the disease by reducing frataxin levels via RNAi. 
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The UAS-fhRNAi line they created reduces frataxin to near undetectable levels and leads to a 
developmental arrest in the larval stage when ubiquitously expressed. Frataxin depleted flies 
show typical hallmarks of FRDA: reduced life span, diminished activities of ISC containing 
enzymes, loss of intracellular iron homeostasis and increased susceptibility to oxidative stress 
(Anderson et al, 2005; Anderson et al, 2008). 
A later study could show that frataxin depletion in motor neurons results in loss of 
mitochondrial membrane potential, reduced ATP production and defects in the axonal transport 
of mitochondria (Shidara & Hollenbeck, 2010). Interestingly, the importance of lipid 
metabolism in FRDA was established in this model. Navarro et al could show that frataxin 
knockdown results in increased fatty acid content and enhanced lipid peroxidation. This study 
also highlights the importance of glial cells in the pathology of the disease. Frataxin depleted 
glia accumulate lipid droplets in the brain and display reduced locomotor activity (Navarro et 
al, 2010). Further research has emphasized the role of mitochondrial iron overload. Frataxin 
depleted flies are hypersensitive to iron, which can be rescued by downregulating mitoferrin, a 
protein responsible for iron transport into mitochondria (Navarro et al, 2015). In a cardiac model 
of FRDA, frataxin depletion recapitulates the impairments found in the hearts of patients 
(Tricoire et al, 2014). 
Overall, this model has been used to successfully mimic loss of frataxin phenotypes and 
serves as an excellent tool to investigate downstream effects of frataxin depletion in a tissue-
specific manner. This line is used as fhRNAi1 in this thesis. 
In 2007, Llorens et al developed a second RNAi model that leads to a more moderate 
frataxin knockdown (to about 30%). In this fhRNAi line, flies are able to develop normally 
under ubiquitous knockdown, permitting a systemic depletion through ubiquitous drivers that 
more closely resembles the human condition. This model also recapitulates hallmarks of FRDA: 
Shortened life span, reduced locomotor ability, involvement of glial cells and increased 
susceptibility to oxidative stress and iron (Llorens et al, 2007; Navarro et al, 2010; Navarro et 
al, 2015). In addition, this model suggests that other metals besides iron may be involved in the 
pathology of FRDA. Zinc, copper, manganese and aluminium levels were increased in frataxin 
knockdown flies and locomotor performance could be improved through activation of metal 
detoxification pathways (Soriano et al, 2016). Due to the lower knockdown, phenotypes 
generally appear later and are less severe. This line has therefore been used to study the efficacy 
of potential therapeutic approaches in the fly. Two studies could show a beneficial effect of 
certain drugs targeting affected pathways. The iron chelator deferiprone, the antioxidant 
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idebenone and the autophagy activator rapamycin all improved life span and motor ability of 
the flies (Soriano et al, 2013; Calap-Quintana et al, 2015). 
This line is used as fhRNAi2 in this thesis. 
1.7.2. A Drosophila fh mutant 
Apart from the two RNAi knockdown models, a third model has recently been developed 
by Chen et al. They identified a missense mutation of fh via a forward genetic EMS (Ethyl 
methane sulfonate) screen which induces a severe loss-of-function. The mutation is located in 
the ISC assembly complex binding domain and results in lethality in the L3/pupal stage. In 
mosaic clones of adult photoreceptor neurons, both iron and lipid accumulation could be 
detected, similar to the phenotypes found in the fhRNAi1 line. This in turn activated the 
Pdk1/Mef2 pathway, a known downstream effect of lipid accumulation in yeast, contributing 
to photoreceptor degeneration (Chen et al, 2016). However, they questioned the role of 
oxidative stress, since ROS levels were not increased and treatment of flies with the antioxidant 
AD4 did not suppress neurodegeneration in their model. 
1.8. Aims of the thesis 
The main goal of this thesis is to further analyse the downstream effects of frataxin 
depletion in a multicellular organism like Drosophila melanogaster. To reach this goal, I first 
wanted to establish the mitochondrially enriched indirect flight muscles as a model tissue for 
the study of Friedreich’s ataxia in the fruit fly to complement the previously described glial 
system. 
Even though frataxin is a mitochondrial protein and Friedreich’s ataxia is closely linked to 
mitochondrial dysfunction, information about mitochondrial dynamics and quality control is 
lacking in most of the existing models. To elucidate this matter, I wanted to examine the effects 
of frataxin deficiency on several parameters playing a key role in mitochondrial homeostasis, 
including morphology, dynamics and degradation. 
Next, I wanted to study if genetic manipulation of mitochondrial homeostasis would be 
able to ameliorate frataxin deficiency. After identifying a positive interaction, the subsequent 
goal was to unravel the molecular and cellular mechanism underlying such an interaction. 
Finally, I wanted to test if pharmacological treatment targeting identified pathways would 
be able to alleviate frataxin phenotypes. 
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2. Material and Methods 
2.1. Material 
2.1.1. Fly strains 
Fly stocks were kept in glass vials containing Drosophila standard medium (cornmeal, agar, 
soy meal, molasses, malt flour, yeast and nipagine as a fungicide). The vials were stored in a 
humid incubator at a temperature of 25°C, a relative humidity of 65 % with a 12 hour light/dark 
cycle. 
Driver Stocks, mutants and balancers 
Genotype Chrom. Details Origin 
w1118 X white mutation 
Bloomington Stock 
Collection #3605 
Atg8aKG07569/FM7c X Atg8a mutant 
Bloomington Stock 
Collection #14639 
actin-Gal4/TM6B III ubiquitous driver 
Bloomington Stock 
Collection #3954 
Repo-Gal4/TM6B III glia cell driver 
Bloomington Stock 
Collection #7415  






PhiC31 integration line for 
germline transformation 
Michael Krahn 
w; D3/TM3 X; III 




Genotype Chrom. Details Origin 
UAS-cherryRNAi II knockdown of cherry 
Bloomington Stock 
Collection #35787 
UAS-fhRNAi1 II strong knockdown of frataxin John P. Phillips 
UAS-fhRNAi1 III strong knockdown of frataxin John P. Phillips 
UAS-fhRNAi2 II 
moderate knockdown of 
frataxin 
Maria D. Moltó 
UAS-nGFP II 




UAS-mitoGFP/CyO III overexpression of mitoGFP 
Bloomington Stock 
Collection #8433 




overexpression of cytosolic 
GFP 
Andrea Brand 
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Albrecht et al, 2011 
UAS-fh II overexpression of frataxin Llorens et al, 2007 
MitoCatalase III 
ubiquitous expression of 
mitochondrial catalase 
William Orr 
UAS-Spargel II overexpression of Spargel Christian Frei 
UAS-SpargelRNAi II knockdown of Spargel 
Bloomington Stock 
Collection #33914 
UAS-Marf II overexpression of Marf Alex Whitworth 
UAS-MarfRNAi II knockdown of Marf 
Bloomington Stock 
Collection #31157 
UAS-Opa1 III overexpression of Opa1 Alex Whitworth 
UAS-Opa1RNAi III knockdown of Opa1 Ming Guo 
UAS-drp1 II overexpression of drp1 Ming Guo 
UAS-drp1RNAi III knockdown of drp1 
Bloomington Stock 
Collection #27628 
UAS-Pink II overexpression of Pink Alex Whitworth 
UAS-PinkRNAi III knockdown of Pink 
Bloomington Stock 
Collection #31282 
UAS-Parkin II overexpression of Parkin Alex Whitworth 
UAS-ParkinRNAi III knockdown of Parkin 
Bloomington Stock 
Collection #31255 
UAS-GFP-Atg8a III overexpression of GFP-Atg8 Thomas P. Neufeld 







UAS-p62 II overexpression of p62 L. Miguel Martins 
UAS-Xbp1-GFP/CyO II overexpression of Xbp1-GFP Pedro Domingos 
UAS-ER-GFP II overexpression of ER-GFP 
Bloomington Stock 
Collection #9898 
UAS-mtRosella/TM3 III overexpression of mtRosella chair stock 
UAS-PERKRNAi III knockdown of PERK 
Bloomington Stock 
Collection #42499 
UAS-Sar1RNAi III knockdown of Sar1 
Bloomington Stock 
Collection #32364 
UAS-Bap31RNAi III knockdown of Bap31 
Bloomington Stock 
Collection #32917 
UAS-ItprA III overexpression of Itpr 
Bloomington Stock 
Collection #30743 
UAS-ItprRNAi III knockdown of Itpr 
Bloomington Stock 
Collection #51795 
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Genotype Chrom. Details Origin 
UAS-PorinRNAi III knockdown of Porin 
Bloomington Stock 
Collection #29572 












knockdown of frataxin and 





co-knockdown of Marf and 
frataxin 
chair stock 
Combined Driver and Responder Stocks 











Glial driver with 













Glial driver with 





Glial driver with 





Muscle driver with 





Muscle driver with 












Muscle driver with 
overexpression of Xbp1-GFP 
chair stock 
Table 1: List of fly stocks 
2.1.2. Buffers and solutions 
Name Components Task 
Blocking Buffer OBB:TBS = 1:1 
membrane blocking for Western 
Blot 
DEPC-H2O 1% DEPC in ddH2O RNA Extraction 
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Name Components Task 
Laemmli buffer 
0.06 M Tris/HCl pH 6,8 
10 % glycerol 
2 % SDS 





0.025 M Tris 
0.2 M glycine 
0.1 % SDS 
SDS-PAGE 
Fixing solution 
4 % paraformaldehyde 
0.5 % Triton X-100 
Fixation of flies for whole 
mounts 
PBS 
137 mM NaCl 
2.7 mM KCl 
4.3 mM Na2HPO4 
1.47 mM KH2PO4 
adjust pH to 7.2 
Dissection of brains and muscles 
PBST 
PBS with 0.1 or 0.5 % Triton 
X-100 
Histology washes (0.1 %) 
Histology AB staining (0.5 %) 
Relaxing solution 
20 mM KH2PO4 
5 mM MgCl2 
5 mM EGTA 
5 mM ATP 
TMRE staining 
RIPA buffer 
50 mM Tris-HCl, pH 8.0 
150 mM NaCl 
1% Igepal CA-630 (NP-40) 





50 mM Tris 
40 mM glycine 
20 % methanol 
0.000375 % SDS 
Western Blot blotting 
TBS 
0.01 M Tris 
0.15 M NaCl 
adjust pH to 7.5 
Western Blot 
TBST TBS with 0.05 % Tween-20 Western Blot washes 
ATP buffer 
100 mM Tris 




0.2 mM NaCitrate 
5 0mM Tris/HCl, pH 7.4 
Aconitase activity 
Carnoy 
99 % Ethanol : chloroform : 
acetic acid = 6 : 3 : 1 
Fixation reagent for paraffin 
sections 
Table 2: List of Buffers and Solutions 
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2.1.3. Oligonucleotides 











































Table 3: List of Oligonucleotides 
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2.1.4. Antibodies 
Description Origin Dilution Application 
mouse anti-Repo 8012 DSHB 1:100 Whole mount 
rat anti-BiP Babraham BT-GB-143P 1:200 Whole mount 
rabbit anti-p62 
Sébastien Gaumer (Nezis et al, 
2008) 
1:500 Whole mount 
goat anti-GFP Rockland 1:100 Whole mount 
goat anti-rabbit Cy3 Jackson 111-165-045 1:200 Whole mount 
goat anti-mouse AF 488 Invitrogen A11029 1:200 Whole mount 
goat anti-mouse Cy3 Jackson Dianova 115-165-146 1:200 Whole mount 
goat anti-rat AF 555 Mol. Probes A-21434 1:200 Whole mount 
donkey anti-goat AF 488 Invitrogen A-11055 1:200 Whole mount 
donkey anti-mouse AF 
555 
Invitrogen A-31570 1:200 Whole mount 
donkey anti-rabbit AF 
594 
Invitrogen A-21207 1:200 Whole mount 
TRITC-conjugated 
Phalloidin 
Sigma-Aldrich 1:500 Whole mount 
DAPI Sigma-Aldrich 1:500 Whole mount 
rabbit anti-actin Sigma Aldrich A2066 1:2500 Western Blot 
mouse anti-Tubulin Sigma Aldrich T9026 1:15000 Western Blot 
rabbit anti-GFP Invitrogen A-6455 1:2500 Western Blot 
rabbit anti-p62 
Gabor Juhasz (Pircs et al, 
2012) 
1:3000 Western Blot 
rabbit anti-EIF2S1 (P-
eIF2α) 
abcam ab32157 1:2000 Western Blot 
goat anti-mouse 680 nm 
LT 
Li-Cor 926-68020 1:15000 Western Blot 
goat anti-rabbit 800 nm 
CW 
Li-Cor 926-32211 1:15000 Western Blot 
Table 4: List of Antibodies 
2.1.5. Chemicals and consumable materials 
Chemicals and consumable materials were purchased from the following suppliers: 
BioRad, Biozym, Braun, Fluca, Intenso, Balur, Kimberley-Clark, Marienfeld, Menzel, Merck, 
Pall, Pharmacia, PeqLab, Polysciences, Qiagen, Roche, Roth, Sarstedt, Schleicher & Schuell, 
Serva, Sigma, TPP and Verbatim. 
Deionized, purified water was taken from the ELGA PURELAB classic water filtration 
system. 
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2.1.6. Kits 
Kit Provider Application 
ATP Bioluminescence Assay 




PeqGOLD TriFast PeqLab RNA Extraction 
QuantiTect Reverse 
Transcription Kit 
Qiagen GmbH Reverse transcription of mRNA 
qPCR Green ROX L Mix highQu GmbH Real-time qPCR 
BIOXYTECH Aconitase-
340 
OxisResearch Aconitase activity assay 
Coomassie Plus Protein 
Assay 
Thermo Scientific Bradford assay 
Table 5: List of Kits 
2.1.7. Equipment 
Machine Provider Application 
Centrifuge 5415D Eppendorf Microcentrifuge 
digital pH/millivolt 
meter 611 
Orion Research pH meter 
Axiophot Zeiss Fluorescence microscope 
Leica M2 Fl III Leica Stereo fluorescence microscope 
TCS SP8 Leica Confocal microscope 
Odyssey Infrared Imaging 
System 
Li-Cor Western Blot detection 
CFX 96 Connect Bio-Rad Light cycler for qPCR 
Stemi 2000 
Stereomicroscope 
Zeiss Fly collection and preparation 
Tecan infinite F500 plate 
reader 




Determination of RNA/DNA 
concentration 
Ultrospec 3000 photometer Pharmacia Biotech 
Bradford and aconitase activity 
assays 
Table 6: List of Equipment 
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2.1.8. Software 
Program Version Provider Application 
CFX Manager 3.1 Bio-Rad 
Operating software of CFX 96 
Connect light cycler 
GraphPad Prism 5.03 GraphPad Software 
Graph design and statistical 
analysis 
LAS X 3.01 Leica 
Operating software of the Leica 
SP8 confocal microscope 
Odyssey Software 1.2.15 Li-Cor 
Operating software of Odyssey 
Imager 
Image Studio Lite 5.2 Li-Cor Western Blot Quantification 
Tecan i-control 1.5.14.0 TECAN 
Operating software of TECAN 
infinite F500 
Fiji 2.0.0 
Schindelin et al, 
2012 
Image processing and analysis 
Office 2013 Microsoft 






Table 7: List of Software 
2.2. Methods 
2.2.1. Analysis of mRNA Expression 
2.2.1.1. RNA extraction 
15 flies, thoraces or 30 heads of the desired age were homogenized in 1 ml TriFast and 
centrifuged for 10 min (12000 g, 4°C). The RNA-containing supernatant was incubated for 
5 min at RT and after addition of 200 µl of chloroform shaken for 10 s. After 2 min at RT and 
another centrifugation step (15 min, 12000 g, 4°C), the upper aqueous phase was transferred to 
a new tube and the RNA was precipitated with 0.5 ml isopropanol and incubated for 10 min at 
RT. After centrifugation (10 min, 12000 g, 4°C) the pellet was washed with 75% ethanol (in 
DEPC-H2O), then solved in 50 µl DEPC-H2O and incubated at 55°C for 10 min. Isolated RNA 
was quantified by measuring the absorbance at 260 nm with a NanoDrop spectrophotometer 
and frozen at -80°C. 
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2.2.1.2. gDNA wipe-out and reverse transcription 
Reverse transcription of 500 ng isolated RNA was carried out with the Quantitect Reverse 
Transcription Kit according to manufacturer’s instructions. The resulting cDNA was stored at 
-80°C. 
2.2.1.3. Quantitative Real-time PCR 
The cDNA was used for qPCR with ORA qPCR Green ROX L Mix on a CFX connect Real-
Time PCR Detection System. The house-keeping gene RP49 was used as an internal control. 
One reaction was composed of: 
Template cDNA 0.5 µl 
SYBR Green 5 µl 
10 µM Primer fw 0.5 µl 
10 µM Primer rv 0.5 µl 
H2O ad 10 µl 
The following PCR program was used for amplification: 
Step/Repeats Temperature Duration 
Pre-denaturation and activation of polymerase 95°C 2 min 
Denaturation 
40x 
95°C 10 s 
Annealing 60°C 10 s 
Elongation 65°C 30 s 
Table 8: qPCR program 
The results were analysed using the comparative CT method. The CT value – standing for 
cycle threshold – represents the number of cycles at which the fluorescence exceeds a specific 
threshold value. The ΔCT value represents the difference between the CT of the target gene and 
the CT of the housekeeping gene. The difference between the ΔCT values of the genotypes 
compared is the ΔΔCT value which is used for the calculation of the final ratio: 
ΔCT (control) = CT (gene of interest) ‒ CT (housekeeping gene) 
ΔCT (sample) = CT (gene of interest) ‒ CT (housekeeping gene) 
ΔΔCT = ΔCT (sample) ‒ ΔCT (control) 
2‒ΔΔCT = final ratio 
The mean ΔCT value of all control reactions for a given gene was used as a reference and 
the other values were referred to this one to obtain the final fold change. 
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2.2.2. Analysis of protein expression 
2.2.2.1. Protein extraction 
For protein isolation, 10 flies, 15 thoraces or 30 heads were homogenized on ice in 100 µl 
Radioimmunoprecipitation assay (RIPA) extraction buffer containing 1x protease inhibitor 
(cOmplete Mini, Roche). After two centrifugation steps (6 min, 10000 rpm, 4°C) the 
supernatant was collected and frozen at -80°C. 
2.2.2.2. SDS-PAGE 
For Polyacrylamide gel electrophoresis (PAGE), 15 µl protein lysate was mixed with 5 µl 
4x Laemmli buffer, boiled at 95°C for 5 min and loaded onto the gel. 
Proteins were separated on 5% stacking and 10% separating gels containing the following 
ingredients: 
5 % Stacking gel 10 % Separating gel 
2.96 ml ddH2O 3.88 ml ddH2O 
0.5 ml 40% Acrylamide-Bisacrylamide 2 ml 40% Acrylamide-Bisacrylamide 
0.5 ml 1 M Tris-HCl pH 6.8 2 ml 1.5 M Tris-HCl pH 8.8 
40 µl 10% SDS 80 µl 10% SDS 
40 µl 10% APS 50 µl 10% APS 
4 µl TEMED 5 µl TEMED 
Table 9: Components of a SDS gel 
Gel runs were performed at 110 V for 2 h. 
2.2.2.3. Semi-dry Western Blot 
After gel electrophoresis, separated proteins were transferred to a nitrocellulose membrane 
through semi-dry blotting. The setup of the blot is shown in Figure 10. Negatively charged 
SDS-protein complexes were transferred to the membrane by applying 400 mA current for one 
hour. 
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Figure 10: Semi-dry blotting setup 
The anode is at the bottom, followed by 3 whatman papers, the membrane, the gel and 3 more whatman papers. 
At the top is the cathode. 
2.2.2.4. Antibody staining 
After blotting, the membrane was agitated in 1x TBS (tris buffered saline) for 5 min to 
wash off residual methanol. The membrane was blocked in OBB:TBS 1:1 for 2 h afterwards to 
prevent unspecific binding of the primary antibody to the membrane. Incubation with the 
primary antibody was performed overnight at 4°C and gentle shaking. After three 10 min 
washing steps with 1x TBST (TBS with Tween 20) to remove excess primary antibody, the 
membrane was incubated with the appropriate secondary antibody for 2 h. Finally, the 
membrane was washed three times with 1x TBST for 10 min and stored in 1x TBS. Western 
blots were scanned with the Odyssey Infrared Imaging System. Protein levels were determined 
by comparing the ratio of the signal intensity from the protein of interest with a housekeeper 
protein using Image Studio Lite. 
2.2.3. Determination of protein concentration for biochemical assays 
To determine the concentration of protein content in samples, a Bradford assay was 
performed using the Coomassie Plus Protein Assay. 
Prior to the assay, the Bradford reagent was allowed to warm up to RT. 20 µl of sample 
were added to 1 ml of reagent and incubated at RT for 5 min. After that the absorbance at 
595 nm was measured with an Ultrospec 3000 Photometer and subtracted from the blank value 
(20 µl of respective buffer added to 1 ml Bradford reagent). The absorbance was then plotted 
against a bovine serum albumin (BSA) standard curve derived from the measurement of a series 
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2.2.4. Analysis of ATP concentration 
2.2.4.1. Sample preparation 
5 thoraces of anesthetized flies were separated from the rest of the body and transferred to 
microcentrifuge cups. After homogenization in 200 µl boiling ATP buffer, the cups were heated 
at 95°C for 2 min and centrifuged (3500 rpm, 1 min). The supernatant was transferred to a new 
cup and diluted 1:3. 
2.2.4.2. Luciferase assay 
ATP levels were measured with the ATP Bioluminescence Assay Kit CLS II. 
In one well of a 96-well plate (Greiner Flat Bottom Black Polystyrol), 50 µl of the diluted 
sample were mixed with 50 µl luciferase. The plate was then placed in the TECAN Infinite F500 
micro plate reader and the luminescence was measured using the following parameters: 
Integration time: 10000 ms 
Settle time: 1000 ms 
Attenuation: Automatic 
The concentration of ATP in µM was determined by plotting the luminescence values 
against an ATP standard curve derived from the measurement of a series of dilutions of ATP 
stock solutions of known concentrations. Finally, dividing the ATP concentration by the protein 
amount obtained from the Bradford assay yielded the normalized ATP concentration. 
2.2.5. Measurement of aconitase activity 
Total aconitase activity was determined from whole individuals using the BIOXYTECH 
Aconitase-340 Spectrophotometric Assay kit. 10 whole flies or 15 thoraces were placed in a 
tube containing 500 µl of ice-cold homogenization buffer and squished. The resulting 
suspension was centrifuged twice at 800 g for 10 min at 4ºC discarding the pellet every time. 
The supernatant was then disrupted by sonication for 30 s with 1 s interval between each pulse. 
For the assay, 100 µl of the extraction was pipetted into cuvettes and complemented by 
adding 100 µl assay buffer, 200 µl substrate, 200 µl enzyme and 200 µl NADP, all part of the 
Aconitase Assay kit. The absorbance at 340 nm was then measured over 25 min at 37°C in the 
Ultrospec 3000 Photometer and the aconitase activity was calculated according to 
manufacturer’s instructions. Finally, the aconitase activity was normalized to the protein 
amount of each sample using the Bradford assay. 
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2.2.6. Germline transformation of mtRosella clones 
2.2.6.1. Microinjection 
The mtRosella vector was kindly provided by Prof Dr. Benedikt Westermann (Böckler & 
Westermann, 2014) and cloned into the Gateway® entry vector pENTR/D-TOPO® by the lab 
technical assistant Gudrun Karch. The transgene was then integrated into the third chromosome 
of the Drosophila genome using the PhiC31 integrating cassette as follows: 
50 ng/µl of plasmid DNA was injected into 30 – 60 min old embryos at 18°C. The embryo’s 
chorion was removed via double-adhesive tape and the embryos were strung together on apple 
juice agar. Afterwards, they were dried for 10 min on silica gel and overlaid with voltalef oil. 
Then, the plasmid DNA was injected near the pole cells through a broken glass needle with a 
pressure of one bar. The injected embryos were placed on apple juice agar plates and kept at 
18°C until hatching. Hatched larvae were transferred to food vials and kept at 25°C until 
eclosion. 
2.2.6.2. Selection of transformants and creation of stable lines 
Adult males were crossed to virgins of the genotype w; D3/TM3. Offspring of the genotype 
w; UAS-mtRosella/TM3 were then crossed among each other to generate the stable line UAS-
mtRosella/TM3. 
Three independent lines were obtained for the construct. 
2.2.7. Whole mount preparation and image acquisition 
2.2.7.1. Brain and muscle dissection 
Adult flies of the appropriate age were fixed in PBS (phosphate buffered saline) with 4% 
paraformaldehyde and 0.5% Triton X-100 for 2 h. Brains or thoraces were then dissected in 
0.1% PBST under the binocular and either mounted directly or stained with antibody. 
For antibody staining, all steps were conducted in the dark. Brains/muscles were washed 
twice for 10 min each with 0.1% PBST and then blocked in 0.5% PBST containing 10% normal 
goat serum (NGS) to prevent non-specific antibody binding. The brains/muscles were incubated 
with primary antibody in 0.5% PBST with 10% NGS overnight at 4°C. On the next day, they 
were washed 5 times for 10 min with 0.1% PBST and incubated with the secondary antibody 
overnight at 4°C. After washing again 5 times for 10 min, the brains/muscles were mounted in 
VectaShield on microscope slides, sealed with nail polish and kept at 4°C in the dark until 
further use. 
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For TMRE staining, muscles were dissected without fixation and the hemithoraces 
incubated with 1 µm TMRE in Relaxing solution for 15 min. After washing twice with 
Relaxing solution for 5 min, they were mounted in VectaShield and immediately imaged. 
Unfortunately, this dye could only be used in muscles, since unfixed tissue is needed for the 
staining and brains did not maintain their integrity during the staining protocol. 
2.2.7.2. Confocal microscopy 
All samples were scanned with a Leica TCS SP8 confocal microscope and image 
acquisition settings were kept constant for every condition. Samples were excited with a UV 
diode at 405 nm, an argon laser at 488 nm (10% tube current), a DPSS laser at 561 nm and a 
helium-neon laser at 594 nm. Emitted signals were detected with a HC PL APO 40x/1.30 Oil 
CS2 objective (brains) or HC PL APO 63x/1.30 Glyc CORR CS2 objective (muscles) at 410-
470nm (DAPI), 490-540nm (GFP, AF488), >565nm (AF555, Cy3), > 595nm (AF594), 
>640nm (AF633). Images were generated at a resolution of 1024 x 1024 pixels. Brains and 
muscles were scanned in z-stacks (1 µm and 0.33 µm, respectively) with 30-35 images per 
brain/muscle. 
For ratiometric analysis of mitoroGFP-Grx1, acquisition parameters were chosen so that 
the 405 nm/488 nm ratio of controls was approximately 1.0. 
2.2.7.3. Image handling and editing 
All confocal images were further processed with the image processing software Fiji 2.0.0 
(Schindelin et al, 2012). In detail, background was subtracted in ImageJ via the ‘Rolling Ball’ 
method (Radius = 50 pixels). Maximum projections of three (muscle images) to thirty (brain 
images) slices were made and the resulting image was again subjected to background 
subtraction. Finally, contrast of each image was adjusted to improve quality of signal. 
2.2.8. Image quantification 
2.2.8.1. Number of giant glial cells 
For the counting of giant glial cells of the inner optic chiasm, brains were co-labelled with 
nuclear GFP and anti-Repo. Brain projections were generated as described above and the 
amount of cells forming the inner crescent in the optic lobe (see Figure 11A) were counted 
manually. Only cells displaying both signals were considered. 
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2.2.8.2. Ratio of mitochondrial to cytosolic TMRE 
For quantification of the ratio of mitochondrial to cytosolic TMRE signal, five flies per 
genotype were analysed. For each fly, three independent squares (1600 µm2 each) of single 
slices were used for the analysis and the results averaged. Mitochondrial and cytosolic (total – 
mitochondrial) TMRE signals were quantified and a ratio of both signals was calculated to 
determine the percentage of mitochondrial signal in both genotypes. In all cases, background 
was subtracted (Rolling Ball; 25 pixel size), images were filtered to improve segmentation 
(Median with Radius = 1) and automatic thresholding (Li method) was used to avoid excessive 
manipulation. 
2.2.8.3. Number of p62-positive vesicles 
For the quantification of p62-positive vesicles, five thoraces per genotype and condition 
were analysed. For each thorax, five independent areas of 1600 µm2 were selected and a z-
projection of 30 single images was generated (diameter: 10 µm). In each random square of 
1600 µm2, the threshold was set using the default method in ImageJ. The particles were then 
analysed with the following options to receive the number of p62 vesicles present in a square: 
Size 30-Infinity, Circularity 0.40-1.00, Include holes. The results of each thorax were averaged. 
For co-localization with GFP-Atg8a or LAMP1-GFP, each p62 vesicle was manually 
identified for co-localization with the respective marker. 
For co-localization with TMRE, each p62 vesicle was manually identified for co-
localization with both pHluorin and dsRed. 
2.2.8.4. GSSG/GSH ratio 
For ratiometric quantification of mitoroGFP-Grx1, each slice of a z-stack was processed 
as follows: After background subtraction in each channel, a ratio image was generated by 
dividing the 405 nm channel (GSSG) by the 488 nm channel (GSH) pixel by pixel. For image 
segmentation, the 488 nm channel was filtered (Median; radius = 1), thresholded with the Li 
method in Fiji and the resulting selection transferred to the 405/488 ratio channel to distinguish 
the mitochondrial region. Pixel intensity was then measured for the selection and averaged over 
all slices. For visual representation, all pixels outside the selection were set to NaN (not a 
number) and the image displayed in false colors using the lookup table “Fire”. 
2.2.9. Paraffin sections of fly brains 
Paraffin sections were performed from 35-day-old adult flies. Flies were strung on a collar, 
fixed for 4 h in carnoy, dehydrated in ethanol three times for 30 min and left overnight in 
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methylbenzoate. The next day, the collars were placed in a 1:1 solution of methylbenzoate/ 
paraffin at 60°C for 1 h, washed 6 times for 30 min each at 60°C in paraffin and finally 
embedded in paraffin. Paraffin sections (7 μm) were made using a Reichert Jung microtome, 
transferred to slides coated with glycerine-BSA and covered in water. The slices were flattened 
on a heating plate at 40°C and left to dry overnight. The next day, the slides were washed twice 
in xylole for 30 min, mounted with DPX and analysed under a fluorescence microscope. 
For quantification of brain vacuolization, the size of the combined medulla and lamina 
region (Figure 24A) and whole vacuole size were measured in Fiji. The affected area was then 
referred to as percentage of total brain area. 
2.2.10. Semi-thin epon plastic sections of fly brains 
For examination of lipid accumulation with light microscopy, semithin epon plastic 
sections from 35-day-old adult fly brains were prepared as follows: Heads were fixed in 5% 
Glutaraldehyd overnight and then dehydrated seven times for 10 min each in ethanol and three 
times for 10 min in propylenoxide. Afterwards, they were kept in a 1:1 solution of 
propylenoxide and Epon overnight and then in Epon for five hours. Finally, they were 
embedded in Epon by keeping them at 60°C overnight. Epon sections (1 µm) were made using 
a microtome, transferred to slides, dried at 50°C and mounted with DPX. 
Lipids were identified by characteristically dark droplet-like structures. 
2.2.11. Life span determination 
To determine the life span of flies, 100 male flies were collected within 24 h after eclosion 
and evenly distributed to four vials without yeast. Every two to three days the flies were 
transferred to new vials containing fresh food. Lifespan experiments were conducted in 
standard cornmeal agar medium. 
2.2.12. Chemical treatment and hyperoxia 
For chemical treatments, Instant Drosophila Medium (Formula 4-24, Carolina Biological, 
North Carolina) was rehydrated with the following chemicals: 15 mM Tauroursodeoxycholic 
acid (TUDCA), 50 µm Rapamycin. As control treatment, Instant Drosophila Medium was 
reconstituted with distilled water (for TUDCA) or dimethyl sulfoxide (DMSO) diluted in 
distilled water (for Rapamycin). Within 24h after eclosion, flies were transferred to vials 
containing the corresponding food. 
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Hyperoxia treatment started one day post-eclosion and was performed by exposing flies in 
a glass container with a constant flux of 99.5% oxygen under a low positive pressure at 25°C 
(Botella et al, 2004). 
2.2.13. Negative geotaxis assay 
Locomotor assays were performed as previously described in Botella et al, 2004. 10-12 
flies per genotype were assessed and each fly was recorded 3 times. The mean value of each fly 
was used for the subsequent analysis. 
2.2.14. Statistical analysis and graphing 
Results were analysed statistically and graphed using GraphPad Prism 5.03. Survival data 
were analysed using the Log-rank (Mantel-Cox) test. In all further experiments, data are 
represented as mean ± s.e.m. Significance was determined by two-tailed T-test or by One-way 
ANOVA with post hoc Dunnett or Tukey Multiple Comparison Test (***: P < 0.001; **: P < 







3.1. Glia and muscles as model tissues to study mitochondrial homeostasis in 
FRDA 
As a mitochondrial protein, loss of frataxin adversely affects mitochondrial function 
(Pandolfo, 2012). Therefore, it appeared interesting to analyse the complete mitochondrial 
network and to study how the cells try to counteract the defects. In this thesis, I decided to forgo 
neurons, even though FRDA is primarily a neurodegenerative disease, However, during my 
previous master thesis (Edenharter, 2013), I could show that concomitant dicer2 co-expression 
(which enhances the effect of RNAi) is necessary in neurons to elicit a mitochondrial 
phenotype, except under prolonged hyperoxic conditions. Unfortunately, dicer2 expression by 
itself already proved to influence mitochondrial morphology in neurons (see Appendix Figure 
38). Therefore, I chose to focus on two other tissues described to be involved in FRDA: glia 
and muscles. 
Glia have already been described as a prime target of frataxin depletion in patients (Morral 
et al, 2010), while muscles display high mitochondrial density. In addition, both tissues share 
the advantage that strong depletion of frataxin (fhRNAi1) is compatible with flies reaching 
adulthood. Frataxin knockdown in glial cells using the Repo-Gal4 driver line has already been 
shown to evoke phenotypes that resemble the human condition, such as locomotor deficits, 
damage to brain integrity and reduction of lifespan (Navarro et al, 2010). In addition, 
influencing iron metabolism in glia alone was able improve fly fitness (Navarro et al, 2015). 
As there is a number of different glial cell populations, I decided to focus on one specific 
subgroup in this work, the giant glial cells (GGC) of the inner optic chiasm (Figure 11A). These 
cells are a specialized form of ensheathing glia that wrap around the axon tracts which project 
between neuropils (Tix et al, 1997). They possess certain characteristics which make them ideal 
for the task: They are large, easily distinguishable from surrounding glial populations and 
localized in the brain region where vacuolization was detected upon frataxin depletion (Navarro 
et al, 2010). 
Drosophila muscles, on the other hand, emerged as a promising tissue to study 
mitochondrial dynamics because of their mitochondrial density. Due to their high energy 
demands, muscles are comprised of a sizeable amount of mitochondria and thus are highly 
sensitive to disturbances in mitochondrial homeostasis. Mitochondria are embedded between 
the myofibrils along their entire length to provide ample supply of ATP to the sarcomeres 
(Figure 11B). Here, I specifically focused on the indirect flight muscles (IFM), as they are easily 
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dissected and visualized, having been used before in the study of other neurodegenerative 
diseases such as Parkinson’s disease (Pesah et al, 2004; Deng et al, 2008; Pogson et al, 2014). 
 
Figure 11: Overview of areas investigated in the glial and muscle systems 
(A) Representative optic lobe of a control fly (Repo-Gal4 > UAS-mitoGFP, UAS-cherryRNAi) labeled with 
mitoGFP (green) and stained for Repo (magenta). Red oval denotes the GGC region of the inner optic chiasm. 
Scale bar represents 40 µm. (B) Representative IFM of a control fly (Mef2-Gal4 > UAS-mitoGFP, UAS-
cherryRNAi) labeled with mitoGFP (green) and stained with Phalloidin (magenta). Mitochondria are organized in 
chains in between the myofibrils. Scale bar represents 10 µm. 
As there has been no previous study describing the effects of targeted frataxin knockdown 
in the Drosophila muscular system, I first wanted to verify if frataxin silencing in muscles using 
the driver line Mef2-Gal4 would reproduce the alterations described in ubiquitous knockdown 
(Figure 12). Interestingly and in contrast to glial specific knockdown (Navarro et al, 2010), 
larval development and pupal eclosion rate were normal, even though fly fitness was severely 
affected. Frataxin depletion led to a severe reduction in both median (from 59d to 9d) and 
maximum (from 62d to 13d) lifespan (Figure 12A). Locomotion of flies was strongly reduced 
already at 3d (66 %) and completely abolished at 5d (90 %; Figure 12B). At this age, flies were 
basically unable to move and mostly remained at the bottom of the vial. In agreement, ATP 
production was reduced in all tested ages, being significantly lower at 5d (66 %) and 10d (50 
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%) (Figure 12C). In line with these results, aconitase activity was already reduced by 40% after 
5d (Figure 12D). 
 
Figure 12: Frataxin depletion in muscles is deleterious 
(A) Life span of frataxin depleted flies is severely lowered. n = 100. (B) Negative geotaxis of flies is diminished 
after 3 days and almost completely abolished after 5 days. n = 12. (C) Frataxin knockdown leads to an age-
dependent reduction in available ATP. n = 5. (D) Aconitase activity is reduced after 5d. n = 3. 
Taken together, loss of frataxin in muscles was enough to recapitulate known hallmarks of 
FRDA and therefore confirmed the feasibility of this tissue for further analysis. 
3.2. Frataxin silencing affects mitochondrial integrity and dynamics 
3.2.1. Mitochondrial morphology is altered 
First, I wanted to determine if and how the mitochondrial network is altered when frataxin 




In glial cells, co-staining with anti-Repo enabled me to determine the position of the nuclei. 
An overview over the optic lobe suggested a difference in the mitoGFP pattern after 35d in the 
GGCs (Figure 13A, B). A closer inspection of this region revealed that mitochondria in control 
flies were more evenly distributed (Figure 13A’), while they were clustered around the nuclei 
in frataxin depleted flies (Figure 13B’). 
 
Figure 13: Mitochondrial morphology and distribution is altered in glia 
(A-B) Representative optic lobes of 35d old control (A; Repo-Gal4 > UAS-mitoGFP, UAS-cherryRNAi) and 
frataxin knockdown flies (B; Repo-Gal4 > UAS-mitoGFP; UAS-fhRNAi1) labeled with mitoGFP (green) and 
stained for Repo (magenta). Scale bar represents 40 µm. (A’-B’) Magnification of the GGC region of the inner 
optic chiasm from A and B, respectively (white squares). Control mitochondria are more evenly distributed (A’), 
while frataxin knockdown mitochondria accumulate around nuclei (B’), forming clusters (arrows). Scale bar 
represents 10 µm. (C) Quantification of the amount of GGCs in control (Repo-Gal4 > UAS-nGFP; UAS-
cherryRNAi) and frataxin deficient flies (Repo-Gal4 > UAS-nGFP, UAS-fhRNAi1). The total number of GGCs 
per brain hemisphere is approximately 25 and is not affected in frataxin knockdown flies. n = 5. 
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Even though the mitochondrial network appeared disturbed, this did not induce loss of glial 
cells (Figure 13C). The total number of GGCs was approximately 25 in both controls and 
frataxin depleted flies at young and advanced ages. 
 
Figure 14: Mitochondrial morphology is disturbed in muscles 
(A-D) Representative IFM labeled with mitoGFP. Scale bars represent 10 µm. (A-B) 1d (A) and 10d (B) old 
control flies (Mef2-Gal4 > UAS-mitoGFP, UAS-cherryRNAi). Mitochondrial morphology appears normal. (C-D) 
1d (C) and 10d (D) old frataxin knockdown flies (Mef2-Gal4 > UAS-mitoGFP, UAS-fhRNAi1). Mitochondrial 
morphology is comparable to controls after 1d, but a strong fragmentation occurs after 10d. Arrows indicate 
‘donut’-like mitochondria. (E) Relative transcription levels of genes involved in mitochondrial dynamics, 
mitochondrial quality control and biogenesis. n = 4. 
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In muscles, mitochondria in control flies formed a continuous network with long, linear 
chains (Figure 14A, B). In frataxin knockdown flies, the mitochondrial network initially did not 
differ from controls (shortly after eclosion; Figure 14C). However, mitochondrial integrity was 
clearly compromised after 10d (Figure 14D). Mitochondria were smaller and rounded, with 
visible gaps in the chain, hinting at increased mitochondrial fragmentation. 
Additionally, hollow, ring-like mitochondria could be observed (arrows), termed ‘donut’-
like mitochondria (Liu & Hajnoczky, 2011). This mitochondrial conformation is thought to be 
an adaptation of the network to stress conditions or an  early stage of mitochondrial degradation 
by mitophagy (Bhandari et al, 2014). 
Since mitochondrial morphology was severely altered, I wanted to evaluate whether 
changes in expression level of genes involved in mitochondrial homeostasis were responsible 
for the observed differences (Figure 14E). I included genes involved in mitochondrial fusion 
and fission (Marf, Opa1 and drp1), mitochondrial quality control (Pink, Parkin) and 
mitochondrial biogenesis (Spargel, Tfam). Spargel and Tfam function as transcriptional 
coactivator and transcription factor, respectively, in mediating mitochondrial biosynthesis 
(Tiefenbock et al, 2010; Islam et al, 2012). Opa1, a fusion gene, was upregulated by one third, 
while drp1, a fission gene, was downregulated by about 50%, suggesting a tendency for 
increased fusion. This seems to be in contrast to the observed mitochondrial fragmentation. 
Remarkably, the expression level of the fusion gene Marf was slightly lower in FRDA flies, 
indicating a unique role for Marf in this context. Pink1 was downregulated to 50%, while Parkin 
levels were unaffected. This was surprising considering that Pink1 and Parkin are known to 
work together in promoting mitophagy. Lastly, both Spargel and Tfam levels were unaffected, 
implying an unaltered regulation of mitochondrial biogenesis. Overall, visible changes in 
mitochondrial morphology could not directly be correlated to adjustments in expression profiles 
of mitochondrial homeostasis genes. 
3.2.2. Mitochondrial membrane potential is compromised 
As mitochondrial structure was unquestionably impaired, I next wanted to ascertain that 
the visible changes were corresponding to a functional damage. Therefore I used the dye 
TMRE, which selectively accumulates in mitochondria that exhibit normal membrane potential. 
In control flies, TMRE co-localized with mitoGFP almost perfectly, both in newly eclosed 
flies and 6d old flies (Figure 15A and B, respectively). This indicates healthy mitochondria with 
normal membrane potential. Interestingly, in 1d old frataxin depleted flies that showed a normal 
mitochondrial structure (Figure 14C), TMRE was already absent in certain mitochondria 
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Figure 15: Mitochondria of FRDA flies lose their 
membrane potential 
Representative IFM labeled with mitoGFP (green) and 
stained with TMRE dye (magenta). Scale bars represent 10 
µm. (A-B) Images of 1d (A) and 6d (B) old control flies 
(Mef2-Gal4 > UAS-mitoGFP, UAS-cherryRNAi). 
MitoGFP and TMRE co-localize in mitochondria.(C) 
Image of 1d old frataxin knockdown fly (Mef2-Gal4 > 
UAS-mitoGFP, UAS-fhRNAi1). TMRE is partially 
localized to mitochondria (arrowhead), partially not 
(arrow). (D) Image of 6d old frataxin knockdown fly. The 
majority of mitochondria are devoid of TMRE. (E) 
Quantification of the ratio of mitochondrial to cytosolic 
TMRE signal from A-D. 1d old control value was set to 1.0. 
n = 5-7. 
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After 6d, there was almost no co-localization between TMRE and mitoGFP anymore, 
implying that most mitochondria show a pathological reduction of membrane potential and 
ultimately lost the ability to produce ATP (Figure 15D). 
Quantification of the ratio of mitochondrial to cytosolic signal confirmed these results 
(Figure 15E). In 1d old frataxin depleted flies, the signal ratio was reduced from 1.0 to 0.5, 
indicating loss of membrane potential in half of the mitochondria. After 6d, the ratio was 
significantly decreased to 0.2, demonstrating substantial mitochondrial deficiency. These 
results suggest that mitochondria are predominantly still intact after eclosion, but rapidly 
deteriorate with age. This is in agreement with the biochemical phenotypes from Figure 12 and 
the mitochondrial morphology from Figure 14, which were also age-dependent. 
In conclusion, frataxin knockdown leads to a disturbance in mitochondrial morphology 
progressing with age. This corresponds to a loss of membrane potential and subsequently 
function, such as ATP production. 
3.2.3. Oxidative stress response is altered 
Another established hallmark of Friedreich’s ataxia is susceptibility to oxidative insult 
(Wong et al, 1999). As in humans, oxidative stress has also been found to be of importance in 
the Drosophila model. Flies lacking frataxin were highly sensitive to oxidative stress, while 
hydroxide scavenging improved FRDA phenotypes. Interestingly, this was also the case for 
glial specific frataxin depletion (Llorens et al, 2007; Anderson et al, 2008; Navarro et al, 2010). 
I wanted to assess whether such sensitivity was related to a redox imbalance. An interesting 
tool for visualization of redox homeostasis directly in vivo is the development of a redox 
sensitive GFP, named roGFP, which changes its excitation maximum from 488 nm to 405 nm 
when oxidized (Hanson et al, 2004). More recently, this tool has been optimized by fusion of a 
glutaredoxine (Grx1) to the roGFP, which allows effective measurement of the ratio of oxidized 
glutathione (GSSG; 405 nm) to reduced glutathione (GSH; 488 nm) (Gutscher et al, 2008). 
Lastly, targeting of roGFP-Grx1 to mitochondria permits the specific measurement of the 
glutathione redox potential within this organelle (Albrecht et al, 2011). I used this mitoroGFP-
Grx1 construct to investigate whether the redox state of the mitochondrial glutathione pool was 
affected. The ratio of controls was set to 1.0 (Figure 16). In glial cells of 35d old flies, the 
405/488 nm ratio was decreased by 0.2 in FRDA flies, meaning that more glutathione was 
present in a reduced state compared to controls (Figure 16A-B). This was surprising, 
considering that oxidative stress, described to be present in this FRDA model, should result in 
an increase in the 405/488 nm ratio. In muscles, the effect was even more pronounced (Figure 
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16C-D). The 405/488 nm ratio was decreased to 0.58 in this tissue. Since this result conflicted 
with the predicted change, I tested the validity of the approach by applying DTT to the flies 
prior to fixation. DTT acts as a strong reductant and shifts roGFP to its most reduced state 
(Albrecht et al, 2011). As expected, DTT reduced the 405/488 nm ratio, to about 0.46 in 
muscles (Figure 16D). This confirms that loss of frataxin shifts the mitochondrial glutathione 
pool to a more reduced state. 
 
Figure 16: Glutathione is reduced upon frataxin silencing 
(A-A’) Representative optic lobes of 35d old control (A; Repo-Gal4 > UAS-mitoroGFP-Grx1) and frataxin 
knockdown flies (A’; Repo-Gal4 > UAS-mitoroGFP-Grx1; UAS-fhRNAi1). Scale bars represent 40 µm. (B) 
Quantification of A-A’. 405/488 nm ratio is reduced in FRDA flies. n = 5. (C-C’) Representative IFM of 6d old 
control (C; Mef2-Gal4 > UAS- mitoroGFP-Grx1) and frataxin knockdown flies (C’; Mef2-Gal4 > UAS-
mitoroGFP-Grx1; UAS-fhRNAi1). Scale bars represent 10 µm. (D) Quantification of C-C’. 405/488 nm ratio is 
almost halved in FRDA flies, similar to the addition of the reductant DTT. n = 5. 
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3.3. Mitochondrial damage activates mitophagy 
Since mitochondria were clearly damaged in frataxin-depleted flies, I wanted to assess if 
these mitochondria were correctly targeted for degradation. Perinuclear arrangement of 
mitochondria as seen in glial cells has been suggested to precede mitophagy in mammalian cells 
(Okatsu et al, 2010). Furthermore, the increased mitochondrial fragmentation observed in 
frataxin-deficient muscles is consistent with mitochondria being targeted for clearance by 
mitophagy (Palikaras & Tavernarakis, 2014). 
3.3.1. The autophagy marker p62 accumulates in frataxin-depleted flies 
To test this hypothesis, I used antibodies against the autophagy marker Ref(2)P (Nezis et 
al, 2008; Pircs et al, 2012), the Drosophila orthologue of mammalian p62 (referred to as p62 
from now on) and looked at brains and muscles. 
 
Figure 17: p62 accumulates in the optic lobe 
Representative optic lobes stained for p62. Scale bar represents 40 µm. (A) 35d old control fly (Repo-Gal4 > UAS-
cherryRNAi). (B-B’’) 35d old frataxin knockdown flies (Repo-Gal4 > UAS-fhRNAi1). P62 accumulates in 
knockdown flies to a variable degree. 
In brains, glial specific knockdown resulted generally in an accumulation of p62 after 35d, 
even though the phenotype was variable. P62 was still present in controls (Figure 17A), 
confirming the expected age-dependant presence of p62 in the brain described before (Nezis et 
al, 2008). However, the staining was clearly increased in frataxin depleted flies (Figure 17B-
B’’). The row from B to B’’ shows a range of phenotypes from little to substantial accumulation 
in the region of the GGCs. 
In muscles, p62 was distributed evenly without forming particular structures in controls 
(Figure 18A). Interestingly, p62 accumulated in vesicle-like structures in frataxin depleted flies 
(Figure 18B). These structures occupied the space of mitochondria and also partially co-





Figure 18: p62 accumulates in vesicle-like structures in muscles 
Scale bars represent 10 µm. (A-B) Representative images of 5d old control (A; Mef2-Gal4 > UAS-mitoGFP, UAS-
cherryRNAi) and frataxin knockdown flies (B; Mef2-Gal4 > UAS-mitoGFP, UAS-fhRNAi1) labeled with 
mitoGFP (green) and stained for p62 (magenta). P62 vesicles are absent in controls, but present in frataxin depleted 
flies and engulf mitochondria (insets). (C-C’’) Representative z-projections of 1d (C), 5d (C’) and 10d (C’’) old 
frataxin deficient flies stained for p62. (D) Quantification of C. The number of p62 vesicles increases significantly 
with age. n = 5. (E) Quantification of p62 protein levels in FRDA flies 1d and 5d post-eclosion compared to 
controls. Significant accumulation of p62 upon frataxin silencing in Drosophila muscles. n = 3. (F) Representative 
p62 Western Blot of 5d old FRDA flies. 
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Furthermore, the amount of vesicles increased in an age-dependent manner (Figure 18C-
D). In a given area (1600 µm2), there were an average of 6 vesicles after 1d, rising to 48 after 
10d, an 8-fold increase. This result was confirmed via Western Blot (Figure 18E). P62 amount 
was already multiplied 4-fold after 1d, rising to 8-fold after 5d, compared to controls. 
Since robust accumulation of p62 is linked to autophagic blockage and inaccurate 
aggregate clearance (Bartlett et al, 2011), I decided to analyse the autophagy pathway in-depth 
to determine which step was potentially inhibited or might represent the limiting factor. 
Importantly, the observed phenotypes are more severe and the progression of the disease is 
faster in muscles than in glia. Moreover, the organelle size in this tissue allows a more accurate 
quantification. 
Therefore, I initially concentrated on muscles for further investigation. To make sure that 
the detected increase in p62 amount was not simply a direct consequence of hyperactivation of 
p62 transcription, I compared p62 mRNA levels of FRDA flies to controls (Figure 19A). P62 
mRNA levels were slightly upregulated by about 25%, but cannot account for the massive 
increase in protein amount seen in Figure 18E. In this line, overexpressing p62 in muscles did 
not induce formation of p62 vesicles as shown in Figure 18B (Figure 19B). 
 
Figure 19: p62 accumulation is not a result of transcription hyperactivation 
(A) P62 mRNA levels of control and frataxin-deficient flies. P62 is slightly upregulated in FRDA flies. n = 5. (B) 
Representative IFM with p62 overexpression (Mef2-Gal4 > UAS-mitoGFP, UAS-p62) labeled with mitoGFP 
(green) and stained for p62 (magenta). No accumulation of p62 vesicles detected. Scale bar represents 10 µm. 
Taken together, these results confirm that the FRDA phenotypes are not a direct 
consequence of p62 upregulation. 
3.3.2. Mitophagy is enhanced in FRDA flies 
As mentioned above, p62 accumulation has been described as a sign of autophagy blockage 
(Bartlett et al, 2011). Therefore my results suggested potential defects in autosomal-lysosomal 
trafficking and/or degradation. Consequently, I examined the autophagic flux to determine the 
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step where autophagic inhibition was occurring. To reach that goal, I used the GFP-tagged 
autophagy markers GFP-Atg8a and LAMP1-GFP to label autophagosomes and lysosomes 
respectively and analysed co-localization with p62. 
 
Figure 20: Analysis of mitophagic flux in Drosophila muscles 
(A-B) Representative IFM of 5d old flies labeled with GFP-Atg8a (A,green; Mef2-Gal4 > UAS-GFP-Atg8a, UAS-
fhRNAi1) or LAMP1-GFP (B,green; Mef2-Gal4 > UAS-LAMP1-GFP, UAS-fhRNAi1) and stained for p62 
(magenta). Arrows denote co-localization of both signals. Scale bars represent 10 µm. (C) Quantification of co-
localization from A (left bar) and B (right bar) in a 1600 µm2 square. Number of co-localized signals are referred 
to total number of p62 vesicles. n = 5. (D) Quantification of Western Blots against GFP-Atg8a and LAMP1-GFP 
using anti-GFP antibody. Slight accumulation of GFP-Atg8a. No accumulation of LAMP1-GFP, but increase in 
free GFP. n = 4. (E) Representative examples of Western Blots against GFP-Atg8a (top) and LAMP1-GFP 
(bottom). 
In frataxin knockdown flies, GFP-Atg8a was broadly distributed in the tissue (Figure 20A), 
with a strong co-localization to the p62 vesicles of around 70% (arrows and Figure 20C, left 
bar). This result suggested a proper recruitment of Atg8a to the p62 vesicles and subsequently 
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autophagosome formation. Regarding the second marker, LAMP1-GFP formed punctate 
structures that partially overlapped with p62 (Figure 20B, arrows). Remarkably, the degree of 
co-localization was much lower than with GFP-Atg8a, only about 20% (Figure 20C, right bar). 
This might indicate a problem in the fusion between autophagosomes and lysosomes. To further 
investigate the cellular autophagic flux, I performed Western Blots against both GFP-fusion 
proteins. GFP-Atg8a accumulated slightly (by about 40%), while no significant increase of 
LAMP1-GFP could be detected (Figure 20D and E), suggesting a working turnover of both 
proteins. Interestingly, I found an increased amount of free GFP in the case of LAMP1-GFP 
(by about 50%), a sign for enhanced turnover of the protein and consequently enhanced 
autophagic flux (Mauvezin et al, 2014). Overall, these results allude to a working autophagic 
flux. Interestingly, the speed of autophagolysosome formation appears to be the limiting factor, 
which might explain the apparent p62 and GFP-Atg8a accumulation. 
Due to the discrepancy between the GFP-fusion marker results and the regular 
interpretation of p62 accumulation as a sign for autophagic impairment, I decided to use an 
additional approach to elucidate this contradiction. The mtRosella transgene consists of a 
mitochondrial-targeted dsRed fluorescent protein fused to a pH-sensitive GFP named pHluorin. 
Under neutral conditions, such as in autophagosomes, green and red signals overlap in 
mitochondria. When they are degraded in the autolysosome, they lose the green pHluorin signal 
due to quenching of the pH-sensitive GFP. This tool has been successfully used before to study 
mitophagy in yeast (Rosado et al, 2008; Böckler & Westermann, 2014), C.elegans (Schiavi et 
al, 2015) and mammalian cell culture (Sargsyan et al, 2015). However, to my knowledge, such 
a tool has been never applied in Drosophila and therefore new transgenic flies were generated 
in Prof. Schneuwly´s laboratory for this thesis. 
In control flies, mtRosella was correctly localized to mitochondria and exhibited both 
signals in all organelles (Figure 21A). In FRDA flies, several mitochondria also displayed both 
signals (Figure 21B), denoting either healthy mitochondria or mitochondria not yet targeted for 
degradation. I focused on those organelles that already displayed p62 signals. Altogether, three 
types of p62-positive mitochondria could be observed: Mitochondria with both pHluorin and 
dsRed signals present (arrowhead and Figure 21C), designating the first step of mitophagy, 
formation of autophagosomes. Vesicles with only dsRed signal left (asterisk and D), 
designating the next step, fusion of the autophagosome with the lysosome and subsequent 
quenching of pHluorin signal. Finally, vesicles without signal left (arrows), designating the 
final stages of mitochondrial clearance. Quantification of the three vesicle types revealed that 
the majority (70%) of p62 vesicles lost both signals, around 25% displayed only dsRed signal, 
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while a small amount (5%) showed both signals (Figure 21E). Since blockage of mitophagy 
would trigger accumulation of p62 vesicles with one or both tags present, mitophagic flux is 
not inhibited. 
 
Figure 21: Application of mtRosella in Drosophila muscles 
(A-B) Representative IFM of 5d old control (A, Mef2-Gal4 > UAS-mtRosella) and 5d old FRDA (B, Mef2-Gal4 
> UAS-mtRosella, UAS-fhRNAi1) flies, labeled with pHluorin (green), dsRed (magenta) and stained for p62 
(yellow). Scale bars represent 10 µm. (A) pHluorin and dsRed co-localize in all mitochondria without presence of 
p62 vesicles. (B). Presence of both signals in all mitochondria that have not been targeted for clearance (p62 
negative). Arrows mark p62 vesicles without mtRosella signal. Arrowhead marks p62 vesicle retaining complete 
mtRosella signal. Asterisk marks p62 vesicle with only dsRed signal. (C) Magnification of p62 vesicle marked 
with arrowhead. (D) Magnification of p62 vesicle marked with asterisk. (E) Quantification of co-localization 
between p62, dsRed and pHluorin signal. The majority of p62 vesicles show no mtRosella signal, a small fragment 
displays both tags, while about one fourth only shows dsRed signal. n = 5. 
Next, I wanted to confirm the results obtained in muscles also in glial cells. Therefore, I 
investigated the distribution of the autophagy markers GFP-Atg8a and LAMP1-GFP in glia of 
35d old flies. Similar to muscles, GFP-Atg8a was distributed within the cytoplasm, both in 
control and frataxin depleted flies (Figure 22A and A’, respectively). Remarkably, the 
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accumulation of p62 in the GGCs (Figure 17) was completely recovered when overexpressing 
GFP-Atg8a. Frataxin knockdown flies displayed a few GFP-Atg8a puncta co-localizing with 
p62 (inset arrow), but the phenotype was much less prominent than in muscles. 
 
Figure 22: Mitophagic flux in glia is enhanced 
(A-A’) Representative optic lobes of 35d old control (A, Repo-Gal4 > UAS-GFP-Atg8a) and FRDA (A’, Repo-
Gal4 > UAS-GFP-Atg8a, UAS-fhRNAi1) flies labeled with GFP-Atg8a (green) and stained for p62 (magenta). 
No p62 accumulation found in FRDA flies. Some GFP-Atg8a puncta co-localize with p62 (inset arrow). Scale 
bars represent 40 µm. (B-B’) Representative optic lobes of 35d old control (B, Repo-Gal4 > UAS-LAMP1-GFP) 
and FRDA (B’, Repo-Gal4 > UAS-LAMP1-GFP, UAS-fhRNAi1) flies labeled with LAMP1-GFP (green) and 
stained for p62 (magenta). Increased p62 signal in GGCs. Lysosomes are in close proximity to p62 dots (inset). 
Scale bars represent 40 µm. (C) Quantification of Western Blots against GFP-Atg8a and LAMP1-GFP using anti-
GFP antibody. The amount of both GFP-tags is significantly reduced in FRDA flies. n = 4. (D) Quantification of 
free GFP in LAMP1-GFP Western Blots. Levels of free GFP are markedly increased in frataxin depleted glia. 
n = 4. (E) Representative examples of Western Blots against GFP-Atg8 (top) and LAMP1-GFP (bottom). 
LAMP1-GFP showed a diffuse pattern in control flies, but formed clear punctate structures 
(arrows) in FRDA flies (Figure 22B-B’). Accumulation of p62 still occurred in these flies, in 
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contrast to GFP-Atg8a overexpression. These results suggest an increase in mitophagic activity 
in glial cells of frataxin depleted flies, similar to muscles. Western Blots further confirmed this: 
In frataxin depleted flies, both GFP-Atg8a and LAMP1-GFP protein levels were reduced 
substantially (Figure 22C-E). The effect was more noticeable for GFP-Atg8a (85% reduction) 
than for LAMP1-GFP (70% reduction). As in muscles, free GFP levels were increased (Figure 
22D-E). However, the effect itself was much stronger (around 300%), implying a robust 
activation of mitophagy in glial cells. Taken together, above results suggest that frataxin 
knockdown results in induction of mitophagy without blockage. 
3.3.3. Promoting autophagy is sufficient to improve FRDA phenotypes 
As indicated above, overexpressing GFP-Atg8a in glial cells seemed to have a positive 
effect on autophagy in glia. The p62 accumulation normally seen in FRDA flies was severely 
reduced in GFP-Atg8a overexpressing flies (Figure 22A’), in contrast to muscles where the 
amount of p62 vesicles remained constant (Figure 20C). In addition, the reduction of the 
corresponding GFP-tagged protein was higher when GFP-Atg8a was overexpressed instead of 
LAMP1-GFP (Figure 22C). Interestingly, GFP-Atg8a contains the full-length protein Atg8a 
(Juhasz et al, 2008), while LAMP1-GFP contains a truncated protein with only the 
transmembrane domain and a C-terminal cytoplasmic tail for organelle targeting 
(Pulipparacharuvil et al, 2005). Altogether, the data suggest that the autophagy marker GFP-
Atg8a is functional and thus able to promote mitochondrial clearance in FRDA flies. In 
agreement with this hypothesis, genetic manipulation of endogenous Atg8a levels via 
overexpression was able to abolish the p62 accumulation as well (Figure 23A). 
Because Atg8a overexpression was able to ameliorate p62 accumulation in glial cells, I 
wanted to examine if other hallmarks of FRDA would also be rescued by promoting mitophagy. 
Therefore I examined locomotor ability, brain vacuolization and lipid accumulation, 
phenotypes that have been described before (Navarro et al, 2010). Neither the wild-type Atg8a 
nor the GFP-tagged form were able to rescue the locomotor deficit of the flies. To assess the 
other two phenotypes I looked at semithin epon plastic sections of 35d old brains. 
Overexpressing the non-functional GFP-tagged LAMP1 displayed the typical phenotype, brain 
vacuolization (arrows) and formation of lipid droplets (arrowheads; Figure 23C). Interestingly, 
Atg8a overexpression resulted in significant reduction of brain vacuolization (arrow), but not 
lipid droplet accumulation (arrowheads; Figure 23D). In conclusion, these results confirm the 
positive effect of mitophagy stimulation on the fly model of FRDA. Enhancing mitophagy 
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seemed to reduce brain degeneration. However, lipid accumulation was unaffected, suggesting 
this phenotype does not depend on the status of mitophagy. 
 
Figure 23: Overexpression of Atg8a in glia partially rescues FRDA phenotypes 
(A) Representative optic lobe of a 35d old FRDA fly overexpressing Atg8a (Repo-Gal4 > UAS-Atg8a, UAS-
fhRNAi1) stained for Repo (green) and p62 (magenta). Atg8a overexpression abolishes p62 accumulation. Scale 
bar represents 40 µm. (B) Negative geotaxis assay of 10d old FRDA flies (Repo-Gal4 > UAS-fhRNAi1) with co-
expression of another transgene (legend). Neither GFP-Atg8a nor Atg8a overexpression are capable of rescuing 
the climbing defect. n = 12. (C-D) Representative semi-thin epon plastic sections of 35d old FRDA flies 
overexpressing LAMP1-GFP (C) or GFP-Atg8a (D). Scale bars represent 50 µm. (C) Presence of lipid droplets 
(arrowheads) and vacuolization of brain tissue (arrows). (D) Atg8a overexpression reduces brain vacuolization 
(arrow), but does not improve lipid accumulation (arrowheads). 
Nevertheless, increasing autophagic flux seemed a promising way to at least partially 
improve the flies’ condition. Therefore I tested whether pharmacological induction of 
autophagy might provide a similar beneficial effect. Rapamycin is a prominent inducer of 
autophagy and has been successfully used in another Drosophila model of FRDA before 
(Calap-Quintana et al, 2015). 
First, I assessed whether Rapamycin would have a positive effect on the locomotor deficit. 
Similar to Atg8a overexpression, Rapamycin was not able to significantly rescue the climbing 
defect, although a slight tendency was present, from 1.01 cm/s to 1.11 cm/s when Rapamycin 
was added (red bars; Figure 24A). Since Atg8a overexpression was able to rescue the 
vacuolization in FRDA flies, but not the locomotor deficit, I was interested if Rapamycin might 
behave the same way. As expected, control flies did not show signs of vacuolization after 35d, 
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with or without Rapamycin treatment (Figure 24C, D). Frataxin knockdown triggered a 
substantial vacuolization near the outer optic chiasm (arrows; Figure 24C’). 
 
Figure 24: Rapamycin fails to ameliorate locomotion or brain vacuolization 
(A) Negative geotaxis assay of 10d old flies. Rapamycin has a minor, but insignificant effect on climbing speed. 
n = 12. (B) Quantification of vacuolization from C’ and D’. No significant reduction of vacuolization area. n = 10. 
The quantified region is marked in C. Me = Medulla; La = Lamina. (C-D’) Representative paraffin sections of 35d 
old flies. Scale bars represent 50 µm. (C and D) Control flies (Repo-Gal4 > UAS-cherryRNAi) fed with normal 
food (C) or 50 µm Rapamycin (D). No apparent holes visible. (C’) FRDA flies (Repo-Gal4 > UAS-fhRNAi1) fed 
with normal food. Major vacuolization occurs at the outer optic chiasm (arrows). (D’) FRDA flies fed with 50 µm 
Rapamycin. Vacuolization is still present (arrows). 
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In contrast to Atg8a overexpression, Rapamycin was unable to restore brain integrity, as 
vacuoles were still present in this case (arrows; Figure 24D’). Again, there was a slight but 
insignificant tendency for a positive effect (decrease of vacuolization area from 6.5% to 5.5%; 
Figure 24B) In conclusion, promoting mitophagy via pharmacological means might be 
beneficial but the effect was insufficient to rescue locomotor ability or brain vacuolization 
significantly in this model. 
3.4. Genetic screen reveals Marf as a major component of FRDA 
3.4.1. Marf knockdown in glial cells rescues locomotor deficit 
Since promoting mitophagy via genetic manipulation had a beneficial on frataxin depleted 
flies in glia, I conducted a forward genetic screen to find additional potential modifiers of FRDA 
phenotypes. 
 
Figure 25: Genetic screen reveals Marf as potential modifier 
Locomotor performance of 10d old flies co-expressing frataxin knockdown and an additional transgene (Repo-
Gal4 > UAS-fhRNAi1, X), except the first bar (Repo-Gal4 > UAS-cherryRNAi). The black square denotes a ‘base’ 
climbing level of FRDA flies, which fluctuates slightly in different fly strains. From all tested interactions, only 









































As mitochondrial morphology and homeostasis were clearly disturbed in my model, I 
focused on relevant genes controlling mitochondrial homeostasis: Genes involved in 
mitochondrial fusion and fission (Marf, Opa1 and drp1), mitochondrial quality control (Pink, 
Parkin) and mitochondrial biogenesis (Spargel). As an additional control to verify the reliability 
of the approach, a constitutively expressed mitochondrial catalase (mitoCatalase) was included, 
since it has been described to improve frataxin deficiency (Anderson et al, 2008). 
I initially evaluated locomotor ability as a comparatively quick and simple readout of the 
genetic interactions (Figure 25). 
Control flies with normal levels of frataxin (Repo-Gal4 > UAS-cherryRNAi) reached a 
speed of about 1.55 cm/s (left bar). All other bars denote frataxin knockdown flies co-
expressing a second construct. As expected, FRDA flies climbed significantly slower 
displaying a speed of 0.8 cm/s. Importantly, co-expression of a second transgene did not alter 
the locomotor ability of FRDA flies significantly (ranging between 0.7 cm/s and 0.9 cm/s upon 
co-expression of GFP and cherryRNAi, respectively). Restoring frataxin levels rescued the 
locomotor deficit completely. Similarly, mitochondrial catalase successfully improved 
climbing speed to 1.32 cm/s. These results confirmed the reliability of the method. From all 
tested interactions, only Marf knockdown was able to rescue the locomotor deficit in a 
significant manner. Climbing speed was restored up to 1.63 cm/s, while Marf overexpression 
decreased climbing speed to about 0.64 cm/s. Since Marf promotes mitochondrial fusion 
(Westermann, 2010b), this result suggests that inhibition of fusion might be beneficial, while 
promoting fusion might be detrimental. The other two genes involved in mitochondrial 
dynamics should therefore elicit a similar response. Interestingly, this was not the case. Both 
Opa1 and drp1 did not alter the locomotor deficit significantly when manipulated. This suggests 
that Marf’s role in mitochondrial dynamics might not be the crucial factor for the rescue. 
Changes in Pink1 and Parkin expression also had no effect on the locomotor ability as all 
genotypes exhibited an equal climbing speed. Lastly, stimulating mitochondrial biogenesis via 
Spargel overexpression failed to amend the locomotor defect. Rather, inhibiting biogenesis via 
Spargel knockdown was highly detrimental for the flies and reduced climbing speed to almost 
zero. 
3.4.2. Marf knockdown ameliorates brain vacuolization and lipid accumulation 
The negative geotaxis assay revealed Marf as a promising modifier of FRDA phenotypes. 
Therefore I wanted to know if Marf knockdown would also rescue other known glial 
phenotypes such as brain vacuolization and lipid accumulation. 
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To assess brain vacuolization, I performed paraffin sections of 35d old fly brains of some 
of the genotypes from the screen above and quantified the area of vacuolization (Figure 26A). 
As expected, FRDA flies showed brain vacuolization in the region of the outer optic chiasm 
(about 6.2%; arrows in Figure 26B). In agreement with the results from the negative geotaxis 
assay, only Marf knockdown restored brain integrity (Figure 26C). Vacuolization was reduced 
to 2.2%, not significantly different from brains of healthy flies (1.3%). Marf overexpression 
exacerbated the phenotype and increased vacuolization to 10.1% (arrows in Figure 26D). No 
other gene tested had an influence on vacuolization (drp1 overexpression is pictured as an 
example; arrows in Figure 26E). 
 
Figure 26: Marf knockdown improves brain vacuolization and lipid accumulation 
(A) Brain vacuolization of 35d old flies co-expressing frataxin knockdown and an additional transgene (Repo-
Gal4 > UAS-fhRNAi1, X), except the first bar (Repo-Gal4 > UAS-cherryRNAi). Only Marf knockdown restores 
brain integrity. n = 7. (B-E) Representative paraffin sections of brains quantified in A. Scale bars represent 50 µm. 
(B) X = UAS-cherryRNAi. Substantial vacuolization present (arrows). (C) X = UAS-MarfRNAi. Complete 
absence of vacuolization. (D) X = UAS-Marf. Vacuoles are enlarged compared to B (arrows). (E) X = UAS-drp1. 
Vacuoles present (arrow). (F-H) Representative semi-thin plastic epon sections of 35 old fly brains. Scale bars 
represent 50 µm. (F) Control fly (Repo-Gal4 > UAS-cherryRNAi). No vacuoles and lipid droplets present. (G) 
Frataxin deficient fly (Repo-Gal4 > UAS-fhRNAi1). Visible brain vacuolization (arrows) and lipid droplet 
accumulation (arrowheads). (H) Fly co-expressing knockdown of frataxin and Marf (Repo-Gal4 > UAS-fhRNAi1, 




Finally, I examined if MarfRNAi would be able to rescue the lipid accumulation as well. 
Semi-thin plastic epon sections revealed that Marf knockdown indeed not only ameliorated the 
brain vacuolization (arrows), but also improved the lipid accumulation considerably compared 
to FRDA flies (arrowheads, Figure 26I and H, respectively). Indeed, brain integrity reached 
almost control fly level (Figure 26G). 
Altogether, Marf knockdown improved three important hallmarks observed upon frataxin 
silencing in glia cells. Therefore I decided to focus on Marf as the most promising modifier in 
order to decipher the molecular mechanism underlying the rescue described above. 
3.4.3. Marf knockdown fails to restore mitochondrial morphology or ameliorate p62 
accumulation 
Above results emphasize the key importance Marf has in the pathology of FRDA. Thus, I 
wanted to evaluate how Marf knockdown facilitates the rescue of FRDA phenotypes in glia. 
Marf has been primarily described as a mediator of mitochondrial fusion (Westermann, 2010b), 
suggesting that it might act through restoration of mitochondrial morphology. Marf is also 
involved in mitophagy, as a substrate of the ubiquitin ligase Parkin (Pallanck, 2013). 
However, other proteins involved in those pathways failed to elicit an effect: Neither drp1 
and Opa1 (involved in mitochondrial dynamics) nor Pink1 and Parkin (involved in mitophagy) 
were able to rescue the locomotor deficit (Figure 25) or the brain vacuolization (Figure 26). 
Taken together, these results hint at another role of Marf in FRDA. Nevertheless, I wanted to 
investigate the potential influence of Marf silencing on the mitochondrial morphology defects 
and p62 accumulation described above in frataxin-deficient glia cells (Figure 13 and Figure 17, 
respectively). 
In agreement with previous results (Figure 13), control flies generally showed small, evenly 
distributed mitochondria in the GGC (Figure 27A). In FRDA flies, mitochondria appeared less 
randomly spread out and more clustered (Figure 27B). Marf knockdown slightly reduced the 
clustering, but failed to restore control morphology (Figure 27C). The situation for p62 was 
comparable: Control flies displayed a faint background staining of p62, but no apparent 
accumulation in the GGCs (red oval, Figure 27A’). Frataxin knockdown resulted in observable 
p62 accumulation in the GGC (Figure 27B’). MarfRNAi was not able to abolish the p62 




Figure 27: Marf knockdown fails to ameliorate mitochondrial morphology or p62 accumulation 
(A-C) Representative GGC region confocal images of control (A, Repo-Gal4 > UAS-mitoGFP, UAS-
cherryRNAi), frataxin knockdown (B, Repo-Gal4 > UAS-mitoGFP, UAS-fhRNAi1) and FRDA flies co-
expressing frataxin and Marf knockdown (C, Repo-Gal4 > UAS-mitoGFP, UAS-fhRNAi1, UAS-MarfRNAi) 
labeled with mitoGFP. Control flies show small, discrete mitochondria, while frataxin knockdown leads to 
clustered mitochondria. Marf knockdown reduces clustering, but does not restore control morphology. Scale bar 
represents 10 µm. (A’-C’) Representative optic lobes of control (A’, Repo-Gal4 > UAS-cherryRNAi), frataxin 
knockdown (B’, Repo-Gal4 > UAS-fhRNAi1) and FRDA flies co-expressing frataxin and Marf knockdown (C’, 
Repo-Gal4 > UAS-fhRNAi1, UAS-MarfRNAi) stained for p62. FRDA flies display p62 accumulation in the GGC 
region, which is still present with additional Marf knockdown (red ovals). Scale bar represents 40 µm. 
These results confirm that neither mitochondrial fusion nor mitophagy seem to be the key 
pathways by which Marf knockdown achieves the rescue of locomotor ability, brain 
vacuolization and lipid accumulation. Additionally, Marf knockdown does not appear to 
directly restore mitochondrial function. 
3.4.4. Genetic screen in muscles reveals tissue-specific interaction with Marf 
MarfRNAi in glia had improved locomotion, brain vacuolization and lipid accumulation 
considerably. Therefore, I was interested if this was a glial-specific effect or if MarfRNAi 
would also amend frataxin-deficient phenotypes in other tissues. For this purpose, I repeated 
the genetic screen of chapter 3.4.1 with the Mef2-Gal4 driver to test whether genetic 
manipulation in muscles leads to the similar results. However, the effect of targeted frataxin 
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silencing in muscles was so dramatic that any co-expression almost completely abolished 
locomotion. Thus, I decided to keep the flies at 18°C during development and post-eclosion. 
This lowers the effect of the UAS/Gal4 driven expression and alleviated the consequences of 
frataxin knockdown slightly. Flies were transferred to room temperature 1 h prior to the assay. 
 
Figure 28: Genetic screen in muscles reveals no modifier for rescue 
Locomotor performance of 10d old flies co-expressing frataxin knockdown and an additional transgene (Mef2-
Gal4 > UAS-fhRNAi1, X), except the first bar and the last two bars (Mef2-Gal4 > X). Black square denotes a 
‘base’ climbing level of FRDA flies, which fluctuates slightly in different fly strains. No genetic interaction 
improved locomotion significantly. n = 12. 
Healthy control flies (Mef2-Gal4 > UAS-cherryRNAi) reached a speed of 2.05 cm/s after 
10d (left bar; Figure 28). Frataxin knockdown in muscles strongly impaired the climbing speed 
even at this permissive conditions. Controls ranged from 0.27 cm/s (UAS-cherryRNAi) to 
0.59 cm/s (UAS-GFP). As expected, co-expression of frataxin (UAS-fh) improved locomotion 
tremendously, to about 1.52 cm/s, but still significantly different from controls. Similarly, 
overexpression of mitochondrial catalase boosted the locomotor ability to 0.94 cm/s, but much 
less than fh overexpression. Surprisingly and in contrast to glia, Marf knockdown in muscles 
exacerbated the locomotor deficit. MarfRNAi flies were basically unable to climb and reached 
an average speed of only 0.05 cm/s. Since overexpression of Marf triggered developmental 










































importance in muscles. To confirm this hypothesis, I also tested the locomotion of flies in which 
Marf was knocked down or overexpressed in a control background (Mef2-Gal4 > UAS-
MarfRNAi or UAS-Marf, respectively). Both manipulations were already harmful in that case: 
Marf knockdown flies reached about 0.46 cm/s, whereas no adult flies were obtained upon Marf 
overexpression (far right bars; Figure 28). The climbing speeds for all other genotypes were not 
significantly different from flies co-expressing control constructs (black square). 
In contrast to glia, Marf knockdown was unable to rescue the locomotor defect of targeted 
frataxin depletion in muscles. Moreover, no additional construct was able to ameliorate the 
locomotor deficit, suggesting that the muscular phenotype in this model is too severe to detect 
improvements via genetic manipulation of mitochondrial dynamics or degradation. 
3.5. ER and ER stress are pivotal elements in FRDA 
Up to this point, my experiments could not resolve the mechanism underlying the 
protection observed by Marf knockdown in glia. In addition to mitochondrial fusion and 
degradation, Marf is also involved in ER-mitochondrial contacts. In mouse fibroblasts, 
Mitofusin 2 tethered mitochondria to the ER to facilitate the uptake of Ca2+ ions and promote 
lipid biosynthesis (Brito & Scorrano, 2008). More recently, Marf has been shown to mediate 
ER stress in a Drosophila model of Parkinson’s disease (Debattisti et al, 2014; Celardo et al, 
2016). Therefore, I wanted to investigate whether the ER was affected in the fly FRDA model. 
3.5.1. ER structure appears intact 
First, I assessed the structure of the ER in glia and muscles using an ER-GFP line. It 
consists of a GFP fused to a KDEL sequence, a C-terminal endoplasmic reticulum retention 
signal and localizes to the ER (K Irvine, personal communication, 2007). For the GGCs, ER-
GFP was clustered around nuclei and extended into the cells (Figure 29A).The same ER-GFP 
patterning was clearly observed in FRDA flies (Figure 29B). However, I cannot rule out the 
possibility of subtle differences that cannot be distinguished with this method due to cell and 
ER size. In muscles, the ER was organized in a ladder-like structure around the actin filaments, 
forming the so-called sarcoplasmic reticulum (Figure 29C). Occasionally, ER-GFP aggregates 
were present in the IFM (arrows). In FRDA flies, the overall organization of the ER was 
conserved (Figure 29D). However, aggregates were both larger and more numerous (arrows). 
These aggregates might be caused by ER swelling, a morphological change associated with 




Figure 29: ER structure is intact 
(A-B) Representative optic lobes of 35d old control (A; Repo-Gal4 > UAS-ER-GFP UAS-cherryRNAi) and 
frataxin knockdown flies (B; Repo-Gal4 > UAS-ER-GFP, UAS-fhRNAi1) labeled with ER-GFP (green) and 
stained for Repo (magenta). ER-GFP is clustered around nuclei and extends into the cells. No apparent difference 
in ER structure (insets). Scale bars represent 40 µm. (C-D) Representative IFM of 6d old control (C; Mef2-Gal4 > 
UAS-ER-GFP, UAS-cherryRNAi) and frataxin knockdown flies (D; Mef2-Gal4 > UAS-ER-GFP, UAS-fhRNAi1) 
labeled with ER-GFP (green) and stained with Phalloidin (magenta). In both cases, the ER appears as a ladder-like 
structure around the actin fibers. Some aggregates are present in controls (arrows), which increase in size and 
number in FRDA flies (arrows). Scale bars represent 10 µm. 
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3.5.2. ER stress response is altered 
Mitochondria-ER contacts and their many roles have recently come to the forefront in 
neurodegenerative diseases (reviewed in Paillusson et al, 2016). One such role is linked to ER 
stress. ER stress in turn activates the three branches of the unfolded protein response (UPR; see 
chapter 1.6.1). 
 
Figure 30: ER stress response is altered in frataxin deficient glia 
(A-B) Representative optic lobes of 35d old control (A; Repo-Gal4 > UAS-Xbp1-GFP, UAS-cherryRNAi) and 
frataxin knockdown flies (B; Repo-Gal4 > UAS-Xbp1-GFP, UAS-fhRNAi1) labeled with Xbp1-GFP (green) and 
stained for Repo (magenta). Xbp1-GFP localizes to nuclei in controls. Nuclear localization is lost upon frataxin 
depletion. Scale bars represent 40 µm. (C-D) Representative optic lobes of 35d old control (C; Repo-Gal4 > UAS-
cherryRNAi) and frataxin knockdown flies (D; Repo-Gal4 > UAS-fhRNAi1) stained for BiP. Accumulation of 
BiP in the GGC region. Scale bars represent 40 µm. 
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To visualize ER-stress, I utilized the Xbp1-GFP reporter. Xbp1 is a transcription factor 
activated by alternative splicing after ER stress and then translocates into the nucleus to activate 
gene transcription. The GFP-tagged reporter only expresses GFP in-frame when IRE1-mediated 
splicing of Xbp1 occurs (Sone et al, 2013). As a second marker, I used an antibody against the 
ER chaperone BiP/GRP78 (called BiP from now on). 
Xbp1-GFP localized to the nucleus in the GGCs of controls, suggesting that the IRE1/Xbp1 
pathway is activated by default in these cells (Figure 30A). This is in agreement with Sone et 
al, who also found Xbp1-GFP localized to glia, but not neurons during fly development. 
Interestingly, nuclear localization was abolished upon frataxin depletion (Figure 30B). In 
contrast, BiP levels were increased in this region after frataxin silencing (Figure 30C-D). These 
results clearly indicate that the ER stress response is modified in glia of FRDA flies, even 
though ER structure appeared to be normal. 
Next, I decided to examine if the ER stress response was also altered in muscles in order 
to discriminate between general and tissue-specific events (Figure 31). 
In contrast to glia, the Ire1/Xbp1 pathway was inactive in normal conditions, as no Xbp1-
GFP signal could be detected in any control muscle (Figure 31A). In frataxin deficient flies, the 
pathway was activated and Xbp1-GFP could be found localized to nuclei, confirmed by 
counterstaining with DAPI (Figure 31B). This represents a striking difference between glia and 
muscles and implies that the ER stress response might vary in a tissue-dependent manner, 
depending on the structure and function of the ER in these tissues. In contrast to glia, qPCR can 
be used in this tissue to assess the transcription levels of Xbp1 and BiP. Both endogenous Xbp1 
and BiP were upregulated about two-fold compared to controls (Figure 31C). Lastly, I assessed 
the third signaling pathway of the UPR by measuring the amount of phosphorylated eIF2α via 
Western Blot (Figure 31D-E). P-eIF2α levels were increased by about 60%. Altogether, these 




Figure 31: All UPR branches are activated in muscles 
(A-B) Representative IFM of 6d old control (A; Mef2-Gal4 > UAS-Xbp1-GFP, UAS-cherryRNAi) and frataxin 
knockdown flies (B; Mef2-Gal4 > UAS-Xbp1-GFP, UAS-fhRNAi1) labeled with Xbp1-GFP (green) and stained 
with DAPI (blue) and Phalloidin (magenta). Xbp1-GFP is present only in FRDA flies and localizes to nuclei, 
confirmed by co-staining with DAPI. Scale bars represent 10 µm. (C) Relative gene expression levels of Xbp1 and 
BiP in 7d old control and FRDA flies. Both Xbp1 and BiP display increased mRNA levels. n = 4-6. (D) 
Quantification of p-eIF2α protein levels in FRDA flies 5 days post-eclosion compared to controls. P-eIF2α levels 
are increased. n = 3. (E) Representative example of a p-eIF2α Western blot from D. 
In conclusion, both glia and muscles exhibited a change in the ER stress response, though 
they differed in the exact reaction. The distinctive demands of the ER in both tissues might be 
the cause for the discrepancy. Importantly, FRDA rises as another neurodegenerative disease 






3.5.3. Marf knockdown reduces ER stress in glial cells 
After confirming the hypothesis that frataxin knockdown induces ER stress in flies, the 
next step was to examine whether Marf knockdown would be able to restore normal ER 
function in the glia. 
To this end, I first determined BiP levels via antibody staining in the GGCs. Compared to 
FRDA flies (Figure 32A), Marf knockdown resulted in a variable amount of BiP reduction, 
ranging from non-visible (Figure 32B) to significant (Figure 32B’). Importantly, about 80% of 
flies displayed substantial reduction (leaning towards Figure 32B’), whereas only about 20% 
exhibited minor reduction (leaning towards Figure 32B). 
 
Figure 32: Marf knockdown reduces BiP accumulation 
(A) Representative optic lobe of a 35d old frataxin depleted fly (Repo-Gal4 > UAS-fhRNAi1, UAS-cherryRNAi) 
stained for BiP. Accumulation of BiP in the GGC region. (B-B’). Representative optic lobes of 35d old FRDA 
flies co-expressing MarfRNAi (Repo-Gal4 > UAS-fhRNAi1, UAS-MarfRNAi) stained for BiP. Various levels of 
BiP staining are present in Marf knockdown flies, ranging from no (B) to substantial (B’) reduction. Scale bars 
represent 40 µm. 
Since the above result strongly implies that Marf knockdown suppresses ER stress in glia, 
I examined if Marf downregulation would also be able to restore nuclear Xbp1-GFP 
localization. As expected, Xbp1-GFP localized to nuclei in control flies, while only a basal BiP 
staining was detected (Figure 33A). Upon frataxin depletion, the nuclear Xbp1-GFP 
localization was abolished and BiP staining increased in the GGC region (Figure 33B). 
Remarkably, Marf knockdown reduced the BiP accumulation as well as restored nuclear Xbp1-




Figure 33: Marf knockdown restores nuclear Xbp1-GFP localization 
(A-C) Representative optic lobes of 35d old flies labeled with Xbp1-GFP (green) and stained for BiP (magenta). 
Scale bars represent 40 µm. (A) Control fly (Repo-Gal4 > UAS-Xbp1-GFP, UAS-cherryRNAi). Xbp1-GFP 
localizes to nuclei, moderate BiP staining in the GGC region. (B) FRDA fly (Repo-Gal4 > UAS-Xbp1-GFP, UAS-
fhRNAi1). Nuclear Xbp1-GFP localization is abolished, while BiP staining is increased. (C) FRDA fly with 
concomitant Marf knockdown (Repo-Gal4 > UAS-Xbp1-GFP, UAS-fhRNAi1, UAS-MarfRNAi). Nuclear Xbp1-
GFP localization is restored in most cells; BiP staining is reduced compared to FRDA flies.  
In summary, Marf downregulation is able to compensate the altered ER stress response and 
reverses the locomotor dysfunction, the brain degeneration and the lipid accumulation. More 
importantly, these results suggest that mitofusin indeed mediates the ER stress response in 
frataxin-deficient glia. Furthermore, the altered ER stress response seems to be of key 
importance in the pathology of the disease. 
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3.5.4. Chemical reduction of ER stress reduces brain vacuolization 
Since above results strongly imply that the rescue of Marf downregulation is tied to its 
function in mediating ER stress, I tested whether a similar effect could be reached by chemical 
treatment. For this purpose I administered tauroursodeoxycholic acid (TUDCA), which has 
already been shown to attenuate ER stress in Drosophila (Debattisti et al, 2014). 
 
Figure 34: TUDCA ameliorates brain vacuolization 
(A) Negative geotaxis assay of 10d old flies. TUDCA does not improve the locomotion in frataxin deficient flies. 
n = 12. (B) Quantification of vacuolization from C’ and D’. n = 11. (C-D’) Representative paraffin sections of 35d 
old flies. Scale bars represent 50 µm. (C, D) Control flies (Repo-Gal4 > UAS-cherryRNAi) fed with control food 
(C) or 15 mm TUDCA (D). No holes present. (C’) FRDA flies (Repo-Gal4 > UAS-fhRNAi1) fed with water. 
Vacuolization occurs (arrows). (D’) FRDA flies fed with 15 mM TUDCA. Administering the chemical reduces 
brain vacuolization (arrow). 
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In the negative geotaxis assay, TUDCA-fed FRDA flies displayed an identical locomotor 
deficit compared to untreated FRDA flies (Figure 34A). However, TUDCA administration was 
able to significantly ameliorate the brain vacuolization of frataxin depleted flies (Figure 34B-
D’). The area measured was reduced from 6.5% to 3.5% in flies treated with TUDCA, a 
reduction of almost 50%. 
In conclusion, reducing ER stress via TUDCA successfully improved one of the hallmarks 
of glial downregulation, but, in contrast to genetic manipulation via Marf knockdown, could 
not restore locomotion. Nevertheless, this highlights ER stress as a promising target for 
treatment of FRDA. 
3.5.5. Genetic screen of MAM genes reveals Porin as another potential modifier of 
FRDA phenotypes 
Next, I wanted to test if modification of other genes involved in MAMs would be able to 
elicit a similar effect to Marf. To this end, I tested Drosophila homologues of known tethering 
proteins where stocks were readily available from stock centers in a negative geotaxis assay: 
Bap31 and Fis1 form a tethering complex involved in Apoptosis signaling, while Itpr and Porin 
form a tethering complex responsible for Ca2+ transfer (reviewed in Paillusson et al, 2016). 
Moreover, I tested another putative MAM regulator, the small GTPase Sar1 (Ackema et al, 
2016), which proved to be lethal when downregulated. Finally, one gene involved in mediating 
the ER stress response was added to the screen, PERK (reviewed in Hetz & Mollereau, 2014; 
Celardo et al, 2016). Altogether, seven lines were tested. 
 
Figure 35: Porin knockdown improves locomotor deficit 
Locomotor performance of 10d old flies co-expressing frataxin knockdown and an additional transgene (Repo-
Gal4 > UAS-fhRNAi1, X), except the first bar (Repo-Gal4 > UAS-cherryRNAi). Only Porin knockdown improved 
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Of all lines, only Porin knockdown displayed a significant increase in locomotor ability 
after 10d compared to FRDA flies (Figure 35). Climbing speed was increased around 22% from 
1.14 cm/s to 1.39 cm/s. This result together with the MarfRNAi rescue suggests that modifying 
MAMs could be an interesting, novel way of ameliorating FRDA phenotypes. 
3.6. Moderate frataxin knockdown as a tool for drug testing in a system-wide 
manner 
Strong frataxin knockdown can serve as a reasonable model for unravelling downstream 
effects of frataxin knockdown in a tissue-specific manner (Anderson et al, 2008; Navarro et al, 
2010; Navarro et al, 2015 and this work). However, the severe frataxin deficiency presents two 
disadvantages: First, ubiquitous silencing triggers pre-adult lethality (Anderson et al, 2005). 
Second, the effects induced are likely too strong to be completely rescued using 
pharmacological approaches (see Figure 24 and Figure 34). 
Thus, I decided to use a second fly model of FRDA exhibiting a more moderate knockdown 
that more closely resembles the situation in patients (Llorens et al, 2007). This model has been 
already successfully used to test certain chemical treatments in Drosophila (Soriano et al, 2013; 
Calap-Quintana et al, 2015). This moderate knockdown line is called fhRNAi2 in this thesis. 
3.6.1. Rapamycin ameliorates p62 accumulation 
I first assessed whether p62 accumulation would also be present in this model. Congruent 
with tissue-specific knockdown, p62 accumulated when frataxin was downregulated 
moderately in the whole fly (Figure 36A-B). P62 levels were increased about two-fold after 7d, 
rising to about seven-fold after 30d. I could also confirm that oxidative stress aggravates p62 
accumulation in young flies. Compared to flies kept in normal conditions, p62 accumulation 
increased from two-fold to four-fold. 
In yeast, rapamycin is able to protect frataxin depleted cells from oxidative damage by 
promoting autophagy (Marobbio et al, 2012). Therefore, I tested whether rapamycin treatment 
would amend the p62 accumulation in this model. In agreement with the yeast study, rapamycin 
lowered the p62 accumulation significantly under oxidative stress conditions, from four-fold 




Figure 36: Rapamycin reduces p62 accumulation under oxidative stress conditions 
(A) Quantification of p62 levels of control (actin-Gal4 > UAS-cherryRNAi) and frataxin knockdown flies (actin-
Gal4 > UAS-fhRNAi2). Strong age-dependent accumulation. Oxidative stress exacerbates the phenotype. n = 3. 
(B) Representative Western Blot of A. (C) Quantification of p62 levels of control and frataxin knockdown flies 
fed with control food or Rapamycin and treated with 2d hyperoxia. Rapamycin significantly reduces p62 
accumulation. n = 3. (D) Representative Western Blot of C. 
This result is in agreement with Calap-Quintana et al, who described that under hyperoxic 
conditions rapamycin acts cytoprotective by enhancing autophagy. 
3.6.2. TUDCA improves Aconitase activity 
TUDCA had already shown a positive effect under strong glial knockdown conditions by 
reducing brain vacuolization (Figure 34). Naturally, it was interesting to test whether 
pharmacological treatment with TUDCA would also be able to restore defects upon moderate 
ubiquitous frataxin silencing. Thus, flies were treated with 15 mM TUDCA, subjected to 2d of 
hyperoxia and their aconitase activity measured (Figure 37). As expected, frataxin depletion 
reduced aconitase activity to 46% in control food. Importantly, TUDCA distribution did not 
alter aconitase activity in control flies. FRDA flies, however, benefitted from the chemical. 
Aconitase activity was increased by about 33% to 67% of control level. This suggests that 




Figure 37: TUDCA improves Aconitase activity 
Aconitase activity of flies exposed to 2d of 
hyperoxia. Frataxin knockdown reduces Aconitase 
activity significantly. TUDCA administration 
improves Aconitase activity by approx. 33%. n = 3. 
 
In conclusion, reducing ER stress via TUDCA treatment is able to improve the flies’ 
condition under moderate ubiquitous frataxin silencing. Thus, the ER component of the disease 






























4.1. Drosophila IFM are suitable for studying effects of frataxin knockdown 
Drosophila muscles are enriched in mitochondria and therefore appear as a promising 
tissue to study the effects of frataxin knockdown on mitochondrial integrity. Indeed, the IFM 
have been previously used to successfully investigate mitochondrial homeostasis in Parkinson’s 
disease (Clark et al, 2006; Deng et al, 2008). Although FRDA in humans is primarily a neuronal 
disorder, effects of frataxin depletion on the skeletal muscles of patients have been reported but 
symptoms are less prominent. Investigation of the calf muscles revealed impaired 
mitochondrial respiration, ATP synthesis and delayed recovery of tissue oxygenation after 
exercise (Lodi et al, 1999; Lynch et al, 2002; Nachbauer et al, 2012). These results could not 
be reproduced by a study using the forearm instead of the calf (Bossie et al, 2016), but the 
authors speculated that the difference might be due to the size and energy demands of the 
muscle type. In mouse, conditional ablation of frataxin produced no defects in the skeletal 
muscles (Puccio et al, 2001), but differentially regulated lipogenesis has been reported in a 
GAA-repeat based model (Coppola et al, 2009). 
Therefore, I first needed to verify that frataxin knockdown in the IFM would trigger 
previously established defects such as decreased energy production and reduced activity of ISC-
containing enzymes. Interestingly, using the Mef2-Gal4 driver line with UAS-fhRNAi1 did not 
induce a developmental arrest as has been reported for ubiquitous or glial specific knockdown. 
With actin-Gal4, larvae failed to enter the pupal stage (Anderson et al, 2005), while Repo-Gal4 
driven knockdown resulted in partial lethality in the pupal stage (Navarro et al, 2010). For Mef2-
Gal4, every fly expressing UAS-fhRNAi1 was able to eclose normally without a developmental 
delay. 
Physiological and biochemical analysis revealed that these flies share the familiar 
symptoms of FRDA: Loss of locomotor ability, reduced ATP levels, aconitase activity and life 
span (Figure 12). In agreement with the human condition, these phenotypes became more 
severe with age. Remarkably, despite the absence of a developmental arrest, the deterioration 
occurred much more rapidly than previously reported for other tissues, allowing a fast analysis 
in an age-dependent manner without having to age the flies for an extended period. This serves 
as an advantage to other tissues. 
Overall, these results prove the suitability of IFM to study downstream effects of frataxin 
depletion. Interestingly, Drosophila skeletal muscles recapitulate defects reported in muscles 
of patients (Lodi et al, 1999; Lynch et al, 2002; Nachbauer et al, 2012), whereas the conditional 
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mouse model shows no phenotype (Puccio et al, 2001). A reason for that might be that the IFM 
in fruit flies are more sensitive to frataxin depletion than mouse skeletal muscles, suggesting 
that fly muscles are a better model tissue than mouse muscles for FRDA studies. Therefore, 
Drosophila also appears an interesting model organism to further study the effects of frataxin 
deficiency on skeletal muscles. 
4.2. Mitochondrial homeostasis is impaired 
As a mitochondrial protein, loss of frataxin is closely linked to a disruption to 
mitochondrial homeostasis (Pandolfo, 2012). However, information about pathways like 
mitochondrial dynamics and quality control is limited and partially contradictory in different 
models. Thus, I was interested in an analysis of the complete mitochondrial network to shed 
light into this matter. 
4.2.1. Mitochondrial morphology is altered 
To evaluate mitochondrial homeostasis in frataxin depleted flies, I first assessed 
mitochondrial morphology in glia and muscles. In glia, mitochondria appeared clustered around 
the nucleus, while they were more evenly distributed in control flies (Figure 13). In muscles, 
mitochondria normally form long chains between the muscle fibres (Figure 11B). In frataxin 
knockdown flies, gaps occurred within the chain and mitochondria were fragmented, with 
additional hollow mitochondria present (Figure 14). Interestingly, mitochondria from flies 
directly post-eclosion displayed mitochondrial organization still similar to controls, suggesting 
they are still mostly functional in this case. 
In both human and rat cell culture, frataxin knockdown triggered the formation of enlarged 
mitochondria (Bolinches-Amoros et al, 2014; Obis et al, 2014), while increased fragmentation 
was observed in yeast and C.elegans (Lefevre et al, 2012; Schiavi et al, 2015). For Drosophila, 
the effects seemed to be tissue-dependent. In dopaminergic neurons, frataxin knockdown had 
triggered enlarged mitochondria under hyperoxic conditions (Edenharter, 2013). However, in 
both glia and muscles, mitochondria appeared fragmented. These results confirm that 
mitochondrial morphology and distribution are altered upon frataxin depletion. Furthermore, 
the mitochondrial response seems dependent on the physiology and adaptation capacity of the 
cell type. Enlarged mitochondria were reported for neuronal (Bolinches-Amoros et al, 2014; 
Edenharter, 2013) and cardiac cells (Obis et al, 2014), while fragmentation was found in 
muscles (Schiavi et al, 2015 and this work) and glia (this work). 
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An analysis of the expression profile in muscles revealed that the alterations in morphology 
coincide with changes in the expression levels of genes involved in mitochondrial dynamics, 
although a similar analysis performed in yeast revealed no significant differences (Lefevre et 
al, 2012). The upregulation of Opa1 and downregulation of drp1 and Pink1 point towards 
increased mitochondrial fusion. Since this result is in contrast to the observed phenotype, these 
changes represent either a compensatory response or a pathological consequence. As 
mitochondrial fragmentation is consistent with targeted degradation (Gomes & Scorrano, 
2013), this might indicate a pathological consequence instead of a cellular adaptation in this 
tissue. 
4.2.2. Morphological changes correlate to physiological consequences 
Mitochondrial fragmentation and perinuclear localization are signs of defective 
mitochondria (Palikaras & Tavernarakis, 2014). TMRE staining in IFM confirmed that the 
visible alterations correspond to a loss of mitochondrial membrane potential (Figure 15). A 
majority of mitochondria are still healthy in young frataxin-depleted flies, while fragmented 
mitochondria of older flies had lost TMRE staining and thus their membrane potential. Since 
mitochondrial membrane potential is important for proper energy production, this result agrees 
with the age-dependent reduction in ATP levels (Figure 12A), known hallmarks of FRDA 
(Koeppen & Mazurkiewicz, 2013). Thus, it is possible to directly correlate visible 
mitochondrial fragmentation to a functional deficit. Importantly, mitochondrial dysfunction 
precedes the morphological changes, since a significant loss of membrane potential is already 
found shortly post-eclosion (Figure 15), while morphology still appears mostly unaffected at 
this age (Figure 14). 
4.2.3. Oxidative stress response is altered 
Susceptibility to oxidative insult is another established feature of FRDA in patients 
(Pandolfo, 2012). However, various models have reported conflicting results with regard to the 
involvement of oxidative stress. For mouse, oxidative stress was present in models with residual 
frataxin expression, whereas it was absent in conditional knockout models (Perdomini et al, 
2013). For Drosophila, increased sensitivity to oxidative stress and successful treatment with 
antioxidants have been reported before (Llorens et al, 2007; Anderson et al, 2008; Navarro et 
al, 2010; Soriano et al, 2013). Still, the role of oxidative stress in frataxin depleted flies has 
been challenged as well, since other studies found no increase in ROS and treatment with 
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antioxidants was unable to improve the flies’ condition (Shidara & Hollenbeck, 2010; Tricoire 
et al, 2014; Chen et al, 2016). 
To address this question in our tissues of interest, I investigated the redox potential of 
mitochondria via a redox-sensitive GFP reporter specific for the glutathione redox pool 
(Albrecht et al, 2011). Glutathione is a powerful cellular antioxidant capable of neutralizing 
reactive oxygen species. It is normally present in cells in a reduced state (GSH) and becomes 
oxidized (GSSG) under oxidative stress conditions by donating an electron (Kaplowitz, 1981). 
In a study of FRDA patients, total GSH levels were reduced in erythrocytes (Piemonte et al, 
2001). The ratio of GSSG to GSH can be used to determine the level of oxidative stress within 
the cell and increased ROS production directly correlates to increased GSSG:GSH levels 
(Armstrong et al, 2010). In various FRDA models, the GSSG:GSH ratio was generally raised 
when frataxin was depleted. This was the case for yeast (Auchère et al, 2008; Bulteau et al, 
2012) and human cell culture (Tan et al, 2003; Bulteau et al, 2012). In mouse, an increase was 
reported for skeletal muscles (Calatrava-Ferreras et al, 2016), while the ratio appeared 
unchanged in neurons (Shan et al, 2013). 
Surprisingly and in contrast to most other models, glutathione was not oxidized, but instead 
even more reduced than in control flies (Figure 16). 
One possible explanation is that the GSSG/GSH ratio was measured at time points where 
mitochondria are strongly affected and less ROS are produced as a byproduct of respiration. In 
agreement, the oxidant-sensitivity of frataxin depleted cells derives directly from a higher 
production of mitochondrial ROS (Tan et al, 2003). This might also partially explain the 
contradicting results regarding the involvement of oxidative stress. Depending on the tissue and 
severity of frataxin knockdown, endogenous ROS levels might be unaffected, but external 
oxidative stress would still elicit detrimental effects (Armstrong et al, 2010). 
To further address this question, it would be interesting to determine the GSH/GSSG ratio 
at earlier time points. Additionally, testing total glutathione levels in the cytosol and 
mitochondria might provide further insight, since glutathione gets transported into 
mitochondria upon frataxin depletion (Auchère et al, 2008; Tan et al, 2003). 
Furthermore, mitochondrial and cytosolic redox states can differ even within the same cell 
depending on the insult (Albrecht et al, 2011). It would also be interesting to test another roGFP 
specific for hydrogen peroxide (H2O2) levels, as H2O2 scavengers have been able to rescue 
frataxin knockdown defects in the fly (Anderson et al, 2008). 
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4.3. Mitophagy is activated and proceeds normally 
Mitochondrial fragmentation is a known prerequisite for clearance by autophagy (Palikaras 
& Tavernarakis, 2014). In frataxin depleted flies, the autophagy marker p62 accumulated in 
both glial cells and muscles (Figure 17 and Figure 18), in agreement with increased amounts 
detected in a cardiac mouse model of FRDA (Huang et al, 2013). In fact, p62 levels were 
increased tremendously in muscle tissue in an age-dependent manner and accumulated in 
vesicle-like structures reminiscent of autophagosomes. These vesicles partially co-localized to 
mitoGFP, indicating that mitochondria might be present in them. As accumulation of p62 has 
been linked to a block in autophagic clearance (Bartlett et al, 2011), I was interested if there 
was a defect in autophagy which would prevent mitochondria from being properly degraded. 
Interestingly, increased numbers of autophagosomes and lysosomes were observed in dorsal 
root ganglia of mouse models (Simon et al, 2004; Al-Mahdawi et al, 2006). In C.elegans, it has 
been shown that autophagy is induced and autophagic flux increases upon frataxin silencing 
(Schiavi et al, 2015). In contrast to my results, the authors describe a decrease in p62 levels in 
the worm. However, frataxin depletion extends longevity in C.elegans, a sharp discrepancy to 
every other model. 
To solve this inconsistency, I performed a detailed analysis of the autophagic flux in 
muscles (Figure 20). The marker GFP-Atg8a was properly recruited to the p62 vesicles, 
suggesting a functional autophagosome formation. The lysosomal marker LAMP1-GFP also 
co-localized to these vesicles, showing that fusion with lysosomes occurs. In addition, both 
proteins did not accumulate in frataxin depleted flies, further confirming a working turnover of 
both proteins. In fact, I could detect increased levels of free GFP, a sign for enhanced turnover 
of the protein and consequently autophagic flux (Mauvezin et al, 2014). The results were even 
more pronounced in glial cells, where reduction of GFP-Atg8a and LAMP1-GFP levels in 
conjunction with increased levels of free GFP hint at an increased autophagic flux, despite a 
slight accumulation of p62 (Figure 22). 
How can this difference be explained? For glial cells, one explanation is the general age of 
the fly. P62 levels increase naturally with age in the brain (Nezis et al, 2008). Indeed, p62 levels 
in the GGC region were highly variable and could be dependent on how severely affected the 
individual fly is. In agreement, overexpression of Atg8a reduced p62 levels in the brain (Figure 
23A). In muscles, p62 accumulation is already evident shortly after eclosion and the pathology 
progresses much more rapidly in this tissue. Therefore, one can speculate that the accumulation 
of defective mitochondria is too substantial within a short amount of time for the autophagic 
machinery to cope with. Even if autophagy is activated and proceeds without inhibition, the 
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machinery is overwhelmed with potential targets, leading to the observed increase in p62 levels, 
as not every organelle can be processed at the same time. Another possible explanation might 
be the structure of mitochondria in muscles. In contrast to glia, mitochondria are organized in 
tight chains, possibly limiting access for the autophagic machinery and consequently slowing 
down turnover. 
To further ensure that the autophagic flux I measured corresponds to a mitophagic flux, I 
utilized the mtRosella biosensor. It has already been used as a powerful tool for visualizing 
mitophagy in vivo in yeast, C.elegans and mammalian cells (Rosado et al, 2008; Böckler & 
Westermann, 2014; Schiavi et al, 2015; Sargsyan et al, 2015). In my case, the majority of 
damaged organelles had lost both pHluorin and dsRed signal, further indicating a proper 
turnover (Figure 21). 
Altogether, these results clearly show that in the fly model, mitophagy is induced, 
mitophagic flux enhanced and can proceed normally. This is in agreement with results from 
other FRDA models such as cell culture, C.elegans (Bolinches-Amoros et al, 2014; Schiavi et 
al, 2015). Moreover, lysosomes and autophagosomes accumulate in the dorsal root ganglia of 
FRDA mouse models (Simon et al, 2004; Al-Mahdawi et al, 2006). These results suggest that 
mitophagy works as a protection mechanism against mitochondrial deficiency when frataxin is 
depleted. Importantly, enhanced autophagic activity appears to be the first biomarker so far 
which is common to all models. 
Unexpectedly, overexpression of GFP-Atg8a reduced p62 accumulation in glial cells while 
overexpression of LAMP1-GFP did not (Figure 23). Since, in contrast to LAMP1-GFP, the 
GFP-Atg8a construct incorporates the full-length protein, this implies that the GFP-tagged 
Atg8a is fully functional and able to stimulate autophagy. Indeed, mCherry-tagged Atg8a has 
been shown to rescue Atg8a null mutants and was able to boost autophagy (Pircs et al, 2012). 
This induction of autophagy by GFP-Atg8a partially ameliorated the brain vacuolization, but 
was unable to restore locomotion or reduce the lipid accumulation, further confirming 
autophagy working as a cytoprotective mechanism in Friedreich’s ataxia. In line with this 
argument, promoting autophagy has also been shown to successfully counteract 
neurodegeneration in Drosophila models of Huntington’s and Parkinson’s disease (Ravikumar 
et al, 2004; Tain et al, 2009). However, enhancing autophagy alone is not sufficient to fully 
combat frataxin deficiency in the FRDA model I utilize. 
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4.4. Frataxin knockdown triggers ER stress 
4.4.1. The UPR is activated in muscles 
ER stress is now considered a hallmark of virtually every neurodegenerative disease, even 
in disorders not actually connected to misfolded proteins. Instead, it can be defined as a more 
general, indirect response to external stressors (Scheper & Hoozemans, 2015). Interestingly, 
increasing evidence has linked the endoplasmic reticulum to many cellular processes also 
disturbed in Friedreich’s ataxia: energy production, lipid and calcium metabolism and apoptosis 
signalling (Hetz & Mollereau, 2014). Few studies have looked at ER stress in FRDA so far. An 
increase in expression or activity of ER stress markers such as ATF4, BiP and phosphorylated 
eIF2α has been described before in cell culture (Lu & Cortopassi, 2007). In another cell culture 
study, frataxin depleted cells were more sensitive to chemically-induced ER stress which in 
turn triggered accumulation of BiP (Bolinches-Amoros et al, 2014). These results suggest that 
frataxin depletion triggers the UPR. 
A thorough investigation of the ER structure in muscles using an ER-targeted GFP revealed 
that the basic structure was intact, forming a ladder-like structure around the actin filaments. 
Interestingly, frataxin depletion resulted in the formation of GFP aggregates, a potential sign of 
ER swelling, which has been connected to cell death (Figure 29). In agreement with previous 
results, all UPR branches were activated in muscles. Xbp1 and BiP mRNA levels were 
increased as were protein levels of phosphorylated eIF2α. In addition, the marker Xbp1-GFP 
localized to nuclei in frataxin depleted flies, a sign for the activation of the Ire1-Xbp1 branch 
(Figure 31). These results clearly show that ER stress is present in frataxin depleted muscles, 
which in turn stimulates the UPR. 
4.4.2. Glia as a special case? 
When examining ER stress markers in glial cells, it initially was surprising that Xbp1-GFP 
already localized to the nucleus of the GGCs in freshly eclosed control flies (Figure 30). 
Interestingly, default activation of the Ire1/Xbp1 pathway has already been described in a 
subpopulation of larval glial cells (Sone et al, 2013). The authors speculated that this phenotype 
is related to the specific role of secretory glial cells in generating the components for the multi-
layered membrane sheaths around neurons. Thus, it is possible that the Ire1/Xbp1-active glia 
protect neurons from their deterioration through this ensheathment. In agreement, the GGCs 
are part of this subpopulation of ensheathing glia (Awasaki et al, 2008). Besides glia, default 
activation of Xbp1-based reporters has also been reported for the larval intestine, fat body, 
certain neurons and developing photoreceptors, as well as for the adult male reproductive 
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system and the intestinal stem cells (Ryoo, 2015). Such activation seems to be pivotal for a 
proper homeostasis of certain tissues, particularly secretory ones. 
In frataxin depleted flies, nuclear Xbp1-GFP staining is abrogated, meaning that this 
pathway is likely shut down. This might represent a pivotal element underlying or at least 
contributing to the brain degeneration observed in these flies. In accordance with muscles, BiP 
levels were increased, hinting at increased levels of ER stress in this tissue as well, even though 
Xbp1 was deactivated. However, BiP is a general marker whose transcription can be activated 
by all pathways. It would be interesting to test the other pathways in this tissue in detail to check 
their activation status. Interestingly, no apparent difference in ER structure could be detected 
and, in contrast to muscles, no GFP aggregates were visible. It cannot be ruled out that changes 
in ER morphology are present, but cannot be resolved with a fluorescent marker like ER-GFP. 
Overall, ER stress also manifests in glia, although the different main role of the ER in both 
tissues may account for the differences. Indeed, skeletal muscles feature a highly specialized 
ER called sarcoplasmic reticulum, which serves mainly as a calcium storage depot and regulates 
its release for muscle contraction (Rayavarapu et al, 2012). 
4.5. Marf knockdown ameliorates FRDA phenotypes in glia by mediating the 
ER stress response 
4.5.1. Marf emerges as a key mediator of FRDA phenotypes 
Since mitochondria were clearly affected, I performed a negative geotaxis assay with genes 
involved in mitochondrial homeostasis to potentially identify modifiers of frataxin phenotypes. 
Interestingly, only Marf knockdown proved highly beneficial. In agreement with Anderson et 
al, 2008, overexpression of the hydrogen peroxide scavenger mitochondrial catalase was also 
able to improve the locomotor deficit, albeit not as profound as Marf. This highlights Marf as 
a key mediator in the pathology. In addition, Marf knockdown resulted in almost complete 
recovery of lipid accumulation and brain vacuolization, whereas manipulation of other genes 
did not influence them (Figure 26). 
4.5.2. Neither mitochondrial dynamics nor mitophagy are crucial for Marf rescue 
Because of Marf’s prominent role in mitochondrial fusion, it would seem likely that the 
inhibition of fusion is the key factor behind the Marf rescue. Importantly, Marf knockdown was 
able to suppress Pink1 and Parkin loss-of-function in Drosophila models of Parkinson’s disease 
and cardiac dysfunction by preventing mitochondrial fusion (Deng et al, 2008; Liu & Lu, 2010; 
Bhandari et al, 2014). However, in these studies Opa1 downregulation and drp1 overexpression 
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showed a similar effect. This was not the case here: Manipulation of Opa1 and drp1 were unable 
to counteract frataxin deficiency the same way Marf downregulation did. Marf knockdown in 
fact changed the mitochondrial morphology, but did not restore control shape (Figure 27A-C). 
Another possibility might have been Marf’s role in mitophagy. Marf’s position in the outer 
mitochondrial membrane makes it a prime target of Pink1 and Parkin for ubiquitination to 
mediate mitophagy (Ziviani et al, 2010). However, modification of both Pink1 and Parkin failed 
to modify FRDA phenotypes. In addition, Marf knockdown failed to abrogate the p62 
accumulation in glia (Figure 27D-F). 
These results imply that the rescue via Marf knockdown is neither a direct consequence of 
restored mitochondrial dynamics nor mitophagy. Interestingly, Marf knockdown was also able 
to rescue phenotypes in two Drosophila models of Parkinson’s disease without directly 
improving mitochondrial function (Celardo et al, 2016). 
4.5.3. Marf knockdown remodels the ER stress response 
Interestingly, human and fly mitofusins have been described to modulate cellular responses 
to ER stress (Munoz et al, 2013; Debattisti et al, 2014). In frataxin depleted glial cells, Marf 
knockdown was able to both restore nuclear Xbp1-GFP localization and reduce BiP 
accumulation in the majority of flies (Figure 32). This clearly highlights the involvement of 
Marf in mediating ER stress and heavily implies that the rescue of FRDA phenotypes by Marf 
knockdown might be connected to resuscitating proper ER function in glia. 
The question remains how Marf knockdown could facilitate restoration of ER function and 
ultimately counteract frataxin deficiency. In the fruit fly, ablating Marf in muscles has been 
shown to induce ER stress (Debattisti et al, 2014). Of particular interest is the function of 
mitofusins within the so called ER mitochondria-associated membranes (MAMs). MAMs 
connect the ER to mitochondria and regulate several essential cellular processes like calcium 
signaling, phospholipid exchange, apoptosis and autophagy (Rowland & Voeltz, 2012). They 
have recently come to the forefront as major contributors to the pathology of various 
neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease (Zampese et 
al, 2011; Cali et al, 2013). Mitofusin has been described as such a tether between mitochondria 
an the ER based on findings in human cell culture (Brito & Scorrano, 2008). Further studies 
corroborated that ablation of Mitofusin results in reduced ER-mitochondrial contacts, leading 
to diminished mitochondrial Ca2+ uptake and lipid transfer (Sebastián et al, 2012; Schneeberger 
et al, 2013; Naon et al, 2016). 
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However, the role of Mitofusins as ER-mitochondrial tethers has been challenged by others 
(Cosson et al, 2012; Filadi et al, 2015; Leal et al, 2016). In these studies, ablation of Mitofusin 
entailed the loss of ER-mitochondria contacts and subsequently reduced Ca2+ uptake by 
mitochondria. Their model places Mitofusin as a tether antagonist preventing excessive 
proximity between the two organelles. Therefore, it remains unclear if Mitofusin serves as an 
agonist or antagonist for ER-mitochondria contacts and more data are needed to resolve this 
issue. 
Importantly, a recent paper has found that increased ER stress signaling is mediated by 
Marf in a Drosophila model of Parkinson’s disease. Reducing mitofusin-ER contacts proved 
neuroprotective independently of restoring mitochondrial function, likely by decreasing 
contacts between defective mitochondria and the ER (Celardo et al, 2016). This result provides 
a possible explanation for my phenotypes: In frataxin deficient flies, defective mitochondria 
accumulate and induce ER stress by tethering through Marf. When Marf is downregulated, 
these contacts are diminished and ER stress signaling is reduced, protecting the glial cells from 
excessive ER stress. Interestingly, it has been shown that Marf mutants display reduced number 
of lipid droplets in addition to alterations in ER and mitochondrial structure (Sandoval et al, 
2014). Furthermore, loss of frataxin induces abnormal sphingolipid synthesis, which are 
synthesized in the ER (Chen et al, 2016). These findings connect the ER stress to altered lipid 
metabolism and provide an explanation how Marf knockdown in glia is able to reduce the lipid 
accumulation and brain vacuolization (Figure 26). 
4.5.4. Marf knockdown is detrimental in muscle tissue 
Because Marf knockdown in glial cells displayed a striking benefit for frataxin depleted 
flies, it seemed likely that reducing Marf levels in the IFM would also prove favorable. 
However, Marf knockdown in muscles not only failed to ameliorate the locomotion of frataxin 
deficient flies, but resulted in diminished locomotor ability (Figure 28). This result can be 
explained by the fact that manipulation of Marf in IFM adversely affects even control flies. 
While Marf knockdown reduced locomotion drastically, overexpression proved 
developmentally lethal. This suggests that maintenance of a specific mitochondrial network is 
of paramount importance in muscles. More specifically, previous results in IFM show that Marf 
downregulation is able to suppress Pink1 and Parkin mutants and this rescue can also be 
obtained by Opa1 downregulation or drp1 overexpression (Deng et al, 2008). By contrast, Opa1 
downregulation or drp1 overexpression are not equivalent to Marf knockdown in my glial 
model of FRDA (Figure 25). It is conceivable that tight regulation of mitochondrial dynamics 
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is more important in muscles than in glia. In agreement with this idea, Marf overexpression in 
glia was viable, in contrast to muscles. 
4.6. Drosophila as a model for testing pharmacological treatments 
4.6.1. ER stress appears a promising, novel target 
As mentioned above, from my tested genetic manipulations, only Marf downregulation 
ameliorated locomotion, brain vacuolization and lipid accumulation (Figure 25 and Figure 26). 
Interestingly, Marf knockdown neither reduced the p62 accumulation nor restored 
mitochondrial morphology (Figure 27). In addition to its role in mitochondrial dynamics and 
mitophagy, Marf is also a putative ER-mitochondria tether and mediates ER stress (Celardo et 
al, 2016). 
The chemical TUDCA is a known attenuator of ER stress and has been able to ameliorate 
defects of Marf mutants in Drosophila (Debattisti et al, 2014). Importantly, TUDCA reduced 
the brain vacuolization of frataxin depleted flies (Figure 34B), further supporting the hypothesis 
that reduction of ER stress is the mechanism behind the influence of Marf on the glial 
phenotypes. In addition, the aconitase activity of FRDA flies could be improved with TUDCA 
when tested in a system-wide manner under moderate knockdown conditions (Figure 37), 
However, TUDCA was not able to amend the locomotor deficit of the flies upon strong 
downregulation in glia (Figure 34A). A possible explanation is the strong knockdown of the 
fhRNAi1 model described in Anderson et al, 2005. So far, drug treatment has only been carried 
out successfully in moderate knockdown conditions. Two studies that showed a beneficial 
effect of deferiprone, idebenone and rapamycin utilized the moderate fhRNAi2 line (Soriano et 
al, 2013; Calap-Quintana et al, 2015). One study, in which flies were treated with methylene 
blue to rescue heart deficiency, applies the strong line fhRNAi1, but use an inducible 
geneswitch driver to downregulate frataxin to about 40%, similar to the moderate line fhRNAi2 
(Tricoire et al, 2014). In the new mutant model, application of myriocin, an inhibitor of 
sphingolipid synthesis, partially suppressed photoreceptor degeneration (Chen et al, 2016). It is 
conceivable that chemical administration alone is not sufficient to completely abolish FRDA 
phenotypes after substantial frataxin depletion. To my knowledge, TUDCA provides the first 
pharmacological treatment that benefits the fly under strong knockdown conditions. 
Overall, these results highlight ER stress as a major contributor to FRDA phenotypes and 
targeting ER stress emerges as a novel therapeutic approach in the treatment of the disease. Of 
course, additional phenotypes will have to be tested to fully grasp the effect of lowering ER 
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stress might have on the fly. In addition, the role of ER stress in other models will have to be 
examined. 
4.6.2. Targeting autophagy shows limited success 
Genetic manipulation of the autophagy pathway in glia had provided beneficial effects on 
FRDA phenotypes in my model, as overexpressing Atg8a reduced brain vacuolization (Figure 
23). Atg8a is involved in autophagosome formation by linking selected cargo to the phagophore 
(Nixon, 2013). Enhancing Atg8a expression has been described to promote basal autophagy 
and in turn enhance longevity and resistance to oxidative stress in Drosophila neurons 
(Simonsen et al, 2008). Therefore, the drug rapamycin as an activator of autophagy was an 
obvious target to test the effect of chemically induced autophagy on glial phenotypes. 
Unfortunately, rapamycin failed to restore brain vacuolization in addition to locomotion 
(Figure 24). This result stands in contrast to previous data, which showed an effect of rapamycin 
in the fruit fly by promoting antioxidant defenses (Calap-Quintana et al, 2015). In their work, 
rapamycin improved locomotion and increased ATP levels. As mentioned above, the most 
striking difference is the use of the moderate fhRNAi2 line for their experiments. Keeping in 
mind that Atg8a overexpression was only able to reduce brain vacuolization while it had no 
effect on locomotion or lipid accumulation, it is reasonable to speculate that chemical activation 
of autophagy is not sufficient to rescue the strong frataxin deficiency in my model. Interestingly, 
Calap-Quintana et al described that rapamycin is able to protect the flies from frataxin 
deficiency by promoting antioxidant defenses, independently of the autophagy induction ability 
of rapamycin. In contrast, my data suggest an involvement of autophagy, since mitophagic flux 
was enhanced in glia and overexpression of Atg8a was sufficient to improve brain vacuolization 
(Figure 22 and Figure 23). However, I cannot exclude that rapamycin reduces the number of 
mitochondria targeted for degradation by increasing antioxidant enzymes that might improve 
mitochondrial condition. When administered in moderate downregulation conditions (fhRNAi2 
line), rapamycin reduced the p62 accumulation under hyperoxia (Figure 36). This seems in 
agreement with Calap-Quintana et al, as they described that autophagy induction by rapamycin 
becomes relevant under external oxidative stress. However, it has not been examined if 
rapamycin would also prevent the age-dependent p62 accumulation. 
4.6.3. Are muscle phenotypes too severe to be rescued by targeting downstream 
effects? 
In contrast to glia, genetic manipulation of both autophagy and mitochondrial dynamics in 
muscles failed to improve frataxin phenotypes. Whereas overexpressing GFP-Atg8a abrogated 
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the p62 accumulation in glia (Figure 22A-A’), the amount of p62 vesicles in muscles was 
unaffected compared to controls (Figure 20C and Figure 18D, respectively). In addition, Marf 
knockdown was detrimental instead of beneficial for locomotion (Figure 28). Since phenotypes 
in the IFM generally were much more severe in muscles than in glia, it becomes conceivable 
that the knockdown might be too strong to suppress frataxin deficiency by targeting 
downstream effects. A noteworthy exception was overexpression of a mitochondrial catalase 
(Figure 28). To address this challenge, it might be interesting to target the iron metabolism, 
since mitochondrial overload is likely one of the first steps of frataxin depletion. In fact, 
mitoferrin downregulation was able to prevent mitochondrial iron overload and subsequent 
deficiency in the moderate fhRNAi2 line (Navarro et al, 2015). 
However, as skeletal muscles are not primarily disturbed in FRDA, affected tissues like 
glia or a system-wide approach appear more suitable for identifying potential treatments. 
4.7. Is the endoplasmic reticulum the master mediator of FRDA phenotypes? 
The endoplasmic reticulum is an important organelle within the cell and its interaction with 
mitochondria through the MAMs is likely a major contributor to several neurodegenerative 
diseases such as Alzheimer’s disease or Parkinson’s disease (Paillusson et al, 2016). Could it 
also be of similar importance in FRDA? Certainly, many of the intracellular responses from 
ER-mitochondria axis disruption are present in various models of the disease: Mitochondrial 
damage, disrupted Ca2+ homeostasis and lipid metabolism, axonal transport damage and 
autophagy induction (Navarro et al, 2010; Shidara & Hollenbeck, 2010; Huang et al, 2013; 
Bolinches-Amoros et al, 2014; Mincheva-Tasheva et al, 2014; Chen et al, 2016 and this work). 
Disruptions to the ER-mitochondria axis provide a mechanism by which these different 
features might arise. Indeed, my results provide evidence that ER stress is present and the UPR 
is activated upon frataxin depletion in fruit flies (Figure 29-Figure 31). In addition, Marf 
downregulation in glial cells restored locomotion and abrogated the lipid accumulation and 
brain vacuolization of FRDA flies. This rescue is likely caused by influencing the ER stress 
response, since other pathways appeared unaffected and TUDCA successfully counteracted the 
brain vacuolization in glia (Figure 34), similar to Marf knockdown. TUDCA also improved 
aconitase activity under moderate knockdown conditions (Figure 37). It is reasonable to 
speculate that Marf is able to mediate such a response since it has been described as an ER-
mitochondria tether (Brito & Scorrano, 2008) and has been implicated in calcium and lipid 
transfer between the ER and mitochondria (Sebastián et al, 2012; Schneeberger et al, 2013). In 
Discussion 
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agreement, mitofusin-mediated ER stress has recently been described to trigger 
neurodegeneration in a Drosophila model of Parkinson’s disease (Celardo et al, 2016). 
Based on frataxin’s role in ISC biogenesis, altered cellular iron metabolism and 
mitochondrial dysfunction resulting from iron overload are likely the primary symptoms of 
frataxin depletion (Pandolfo, 2012). Therefore mitochondrial damage, which manifests as loss 
of membrane potential and energy production, probably results directly from disturbance in 
frataxin levels. Altered ER-mitochondria contacts, mediated through Marf, might then be 
pivotal in causing the other known hallmarks of FRDA. In line with this argument, a genetic 
screen of MAM genes revealed that Porin knockdown was also able to significantly rescue 
negative geotaxis (Figure 35). Interestingly, Porin is located in the mitochondrial membrane 
and promotes Ca2+ exchange with the ER, similar to Marf (Szabadkai et al, 2006). 
To provide conclusive evidence for this hypothesis, it will also be necessary to utilize 
methods that reliably quantify ER-mitochondrial distance using electron microscopy 
techniques. Unfortunately, it is not possible to apply them to glia due to their electron-density 
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6.1. Supplemental figures 
 
Figure 38: Dicer2 expression in dopaminergic neurons influences mitochondrial morphology 
Representative images of dopaminergic neurons stained with anti-TH (marks nuclei; red channel) and labelled 
with mitoGFP (green channel). Dicer2 expression alone results in enlarged mitochondria, while frataxin 




Figure 39: Glia show high electron-
density 
Transmission electron microscopy image 
of a Drosophila brain. Glial cells (G) 
show a high electron-density compared 
to neurons (N), which makes identifying 
subcellular structures like mitochondria 
(m) difficult (adapted from Navarro et al, 
2010). 
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